Prof Robert Colebunders

All Stories

1. 
   Mvolo County, an Onchocerciasis Endemic Area in Western Equatoria State, South Sudan: An Entomological Study to Prepare for a “Slash and Clear” Community-Based Vector Control Intervention

   Article • Research and Reports in Tropical Medicine, June 2024, Taylor & Francis

   Prof Robert Colebunders

2. 
   Onchocerciasis-associated epilepsy and biomarkers

   Article • PLoS Neglected Tropical Diseases, May 2024, PLOS

   Prof Robert Colebunders

3. 
   Evaluating epilepsy management in an onchocerciasis-endemic area: Case of Maridi, South Sudan

   Article • Seizure, May 2024, Elsevier

   Prof Robert Colebunders

4. 
   Onchocerciasis-associated epilepsy: Charting a path forward

   Article • Seizure, April 2024, Elsevier

   Prof Robert Colebunders

5. 
   Rapid diagnostic testing for onchocerciasis in Maridi (South Sudan) before and after improving elimination strategies: a repeated cross-sectional survey

   Article • Open Research Europe, March 2024, Faculty of 1000, Ltd.

   Prof Robert Colebunders

6. 
   Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study

   Article • PLoS Neglected Tropical Diseases, March 2024, PLOS

   Prof Robert Colebunders

7. 
   Chorioretinitis among Immigrant and Travellers. Comment on Mansour et al. Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East. Diagnostics 2023, 13, 3626

   Article • Diagnostics, February 2024, MDPI AG

   Prof Robert Colebunders

8. 
   Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed

   Article • Infectious Diseases of Poverty, January 2024, Springer Science + Business Media

   Prof Robert Colebunders

9. 
   Integration of onchocerciasis morbidity management and disability prevention services in the healthcare system in Tanzania: a call for action and recommendations

   Article • Tropical Diseases Travel Medicine and Vaccines, January 2024, Springer Science + Business Media

   Prof Robert Colebunders

10. 
    Methodological challenges for conducting case-control studies to investigate the association between onchocerciasis and epilepsy including nodding syndrome

    Article • Brain Communications, December 2023, Oxford University Press (OUP)

    Prof Robert Colebunders

11. 
    Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on Onchocerca volvulus

    Article • F1000Research, December 2023, Faculty of 1000, Ltd.

    Prof Robert Colebunders

12. 
    Rapid diagnostic testing for onchocerciasis in Maridi (South Sudan) before and after improving elimination strategies: a repeated cross-sectional survey

    Article • Open Research Europe, November 2023, Faculty of 1000, Ltd.

    Prof Robert Colebunders

13. 
    Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study

    Article • BMC Infectious Diseases, November 2023, Springer Science + Business Media

    Prof Robert Colebunders

14. 
    Accessibility to formal education among persons with epilepsy in Mahenge, Tanzania

    Article • Epilepsy & Behavior, November 2023, Elsevier

    Prof Robert Colebunders

15. 
    Persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle belt of Ghana

    Article • Tropical Medicine & International Health, October 2023, Wiley

    Prof Robert Colebunders

16. 
    Procedure for Handling and Storage of Onchocerca volvulus Microfilariae Obtained from Skin Snips for Downstream Genetic Work

    Article • Tropical Medicine and Infectious Disease, September 2023, MDPI AG

    Prof Robert Colebunders

17. 
    Disability assessment among persons with epilepsy in Mahenge, an onchocerciasis-endemic area in Tanzania: A cross-sectional study

    Article • Epilepsy & Behavior, September 2023, Elsevier

    Prof Robert Colebunders

18. 
    The onchocerciasis hypothesis of nodding syndrome

    Article • PLoS Neglected Tropical Diseases, August 2023, PLOS

    Prof Robert Colebunders

19. 
    Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin

    Article • Infectious Diseases of Poverty, August 2023, Springer Science + Business Media

    Prof Robert Colebunders

20. 
    Mortality among persons with epilepsy in onchocerciasis-endemic and non-endemic areas of sub-Saharan Africa: A systematic review and meta-analysis

    Article • Seizure, August 2023, Elsevier

    Prof Robert Colebunders

21. 
    Quality of life of persons with epilepsy in Mahenge, an onchocerciasis-endemic area in Tanzania: A cross-sectional study

    Article • Epilepsy & Behavior, August 2023, Elsevier

    Prof Robert Colebunders

22. 
    Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study

    Article • The Lancet Global Health, August 2023, Elsevier

    Prof Robert Colebunders

23. 
    Assessing Onchocerca volvulus Intensity of Infection and Genetic Diversity Using Mitochondrial Genome Sequencing of Single Microfilariae Obtained before and after Ivermectin Treatment

    Article • Pathogens, July 2023, MDPI AG

    Prof Robert Colebunders

24. 
    Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study

    Article • PLoS Neglected Tropical Diseases, June 2023, PLOS

    Prof Robert Colebunders

25. 
    Nodding syndrome, a case-control study in Mahenge, Tanzania: Onchocerca volvulus and not Mansonella perstans as a risk factor

    Article • PLoS Neglected Tropical Diseases, June 2023, PLOS

    Prof Robert Colebunders

26. 
    Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness

    Article • PLoS Neglected Tropical Diseases, May 2023, PLOS

    Prof Robert Colebunders

27. 
    ASSOCIATION OF ONCHOCERCIASIS NODULE PREVALENCE IN MOTHERS AND THE DEVELOPMENT OF EPILEPSY IN THEIR CHILDREN IN MAHENGE, AN ONCHOCERCIASIS-ENDEMIC AREA OF TANZANIA: A CASE-CONTROL STUDY

    Article • International Journal of Infectious Diseases, May 2023, Elsevier

    Prof Robert Colebunders

28. 
    Case definitions for onchocerciasis-associated epilepsy and nodding syndrome: A focused review

    Article • Seizure, April 2023, Elsevier

    Prof Robert Colebunders

29. 
    Onchocerciasis-associated epilepsy: an update and future perspectives

    Article • Trends in Parasitology, February 2023, Elsevier

    Prof Robert Colebunders

30. 
    How to decrease the epilepsy disease burden in sub-Saharan Africa?

    Article • Epilepsy & Behavior, February 2023, Elsevier

    Prof Robert Colebunders

31. 
    Nodding Syndrome: Clinical Characteristics, Risks Factors, Access to Treatment, and Perceptions in the Greater Mundri Area, South Sudan

    Article • Pathogens, January 2023, MDPI AG

    Prof Robert Colebunders

32. 
    Impact of COVID-19 on the well-being of children with epilepsy including nodding syndrome in Uganda: A qualitative study

    Article • Epilepsy & Behavior, January 2023, Elsevier

    Prof Robert Colebunders

33. 
    Nodding syndrome, populations at risk need to be aware this is a preventable condition

    Article • Brain Communications, January 2023, Oxford University Press (OUP)

    Prof Robert Colebunders

34. 
    Nodding Syndrome, a Case-control Study in Mahenge, Tanzania: <em>Onchocerca volvulus </em>and not <em>Mansonella </em><em>perstans</em> as Risk Factor

    Article • December 2022, MDPI AG

    Prof Robert Colebunders

35. 
    COVID-19 in Low and Middle Income Countries

    Article • Pathogens, November 2022, MDPI AG

    Prof Robert Colebunders

36. 
    Adherence to COVID-19 preventive measures in Sub-Saharan Africa during the 1st year of the pandemic: Pooled analysis of the International Citizen Project on COVID-19 (ICPCovid) surveys

    Article • Frontiers in Public Health, November 2022, Frontiers

    Prof Robert Colebunders

37. 
    New vector of River blindness identified in Africa

    Article • PLoS Neglected Tropical Diseases, November 2022, PLOS

    Anne Laudisoit, Prof Robert Colebunders

38. 
    High Prevalence of Glaucoma among Patients in an Onchocerciasis Endemic Area (Mahenge, Tanzania)

    Article • Pathogens, September 2022, MDPI AG

    Prof Robert Colebunders

39. 
    Enhanced surveillance of monkeypox in Bas-Uélé, Democratic Republic of Congo: the limitations of symptom-based case definitions

    Article • International Journal of Infectious Diseases, September 2022, Elsevier

    Prof Robert Colebunders

40. 
    Infectious Diseases Institute at Makerere University College of Health Sciences: a case study of a sustainable capacity building model for health care, research and training

    Article • African Health Sciences, August 2022, African Journals Online (AJOL)

    Prof Robert Colebunders

41. 
    Community Knowledge, Attitudes and Practices Regarding Onchocerciasis in Rural Villages With a High Epilepsy Prevalence in Mahenge, Tanzania: A Qualitative Study

    Article • July 2022, MDPI AG

    Prof Robert Colebunders

42. 
    Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281

    Article • Pathogens, June 2022, MDPI AG

    Prof Robert Colebunders

43. 
    Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring

    Article • Diagnostics, June 2022, MDPI AG

    Prof Robert Colebunders

44. 
    Enhanced surveillance of monkeypox in Bas-Uélé, Democratic Republic of Congo: the limitations of symptom-based case definitions

    Article • June 2022, Cold Spring Harbor Laboratory Press

    Prof Robert Colebunders

45. 
    ‘There Were Moments We Wished She Could Just Die’: The Highly Gendered Burden of Nodding Syndrome in Northern Uganda

    Article • Qualitative Health Research, May 2022, SAGE Publications

    Prof Robert Colebunders

46. 
    Psychosocial Factors Associated With Adherence to COVID-19 Preventive Measures in Low-Middle- Income Countries, December 2020 to February 2021

    Article • International Journal of Public Health, May 2022, Frontiers

    Prof Robert Colebunders

47. 
    High COVID-19 Vaccine Acceptance among Eye Healthcare Workers in Uganda

    Article • Vaccines, April 2022, MDPI AG

    Prof Robert Colebunders

48. 
    Ivermectin for malaria control in mass drug administration programmes

    Article • The Lancet Infectious Diseases, April 2022, Elsevier

    Prof Robert Colebunders

49. 
    The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey

    Article • Pathogens, March 2022, MDPI AG

    Prof Robert Colebunders

50. 
    Defining post-COVID condition

    Article • The Lancet Infectious Diseases, March 2022, Elsevier

    Prof Robert Colebunders

51. 
    Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.

    Article • International Journal of Infectious Diseases, March 2022, Elsevier

    Prof Robert Colebunders

52. 
    Community knowledge, attitudes, and practices regarding epilepsy in Mahenge, Tanzania: A socio-anthropological study in an onchocerciasis-endemic area with a high prevalence of epilepsy

    Article • Epilepsy & Behavior, March 2022, Elsevier

    Prof Robert Colebunders

53. 
    Impact of the COVID-19 pandemic on persons with epilepsy in Uganda: A descriptive cross-sectional study

    Article • Epilepsy & Behavior, March 2022, Elsevier

    Prof Robert Colebunders

54. 
    Using Andersen’s model of health care utilization to assess factors associated with COVID-19 testing among adults in nine low-and middle-income countries: an online survey

    Article • BMC Health Services Research, February 2022, Springer Science + Business Media

    Prof Robert Colebunders

55. 
    Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

    Article • Pathogens, February 2022, MDPI AG

    Prof Robert Colebunders

56. 
    The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door to Door Survey

    Article • February 2022, MDPI AG

    Prof Robert Colebunders

57. 
    Community perception of epilepsy and its treatment in onchocerciasis-endemic villages of Maridi county, western equatoria state, South Sudan

    Article • Epilepsy & Behavior, February 2022, Elsevier

    Prof Robert Colebunders

58. 
    Adherence to COVID-19 Preventive Measures among Dental Care Workers in Vietnam: An Online Cross-Sectional Survey

    Article • International Journal of Environmental Research and Public Health, January 2022, MDPI AG

    Prof Robert Colebunders

59. 
    Prevalence and Risk Factors Associated with Epilepsy in Six Health Districts of Mali: A Community-Based Cross-Sectional and Nested Case-Control Study

    Article • Neuroepidemiology, January 2022, Karger Publishers

    Prof Robert Colebunders

60. 
    Cardiovascular risk factors and clinical outcomes of patients hospitalized with COVID-19 pneumonia in Somalia

    Article • Therapeutic Advances in Infectious Disease, January 2022, SAGE Publications

    Prof Robert Colebunders

61. 
    Adults’ Acceptance of COVID-19 Vaccine for Children in Selected Lower- and Middle-Income Countries

    Article • Vaccines, December 2021, MDPI AG

    Prof Robert Colebunders

62. 
    Adherence to COVID-19 preventive measures among dental care workers in Vietnam: an online cross-sectional survey

    Article • December 2021, Research Square

    Prof Robert Colebunders

63. 
    Treatment of Pregnant Women with Ivermectin during Mass Drug Distribution: Time to Investigate Its Safety and Potential Benefits

    Article • Pathogens, December 2021, MDPI AG

    Prof Robert Colebunders

64. 
    Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis

    Article • Life, November 2021, MDPI AG

    Prof Robert Colebunders

65. 
    Risk Factors for Nodding Syndrome and Other Forms of Epilepsy in Northern Uganda: A Case-Control Study

    Article • Pathogens, November 2021, MDPI AG

    Prof Robert Colebunders

66. 
    Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum

    Article • Parasites & Vectors, November 2021, Springer Science + Business Media

    Prof Robert Colebunders

67. 
    A peer support group intervention to decrease epilepsy-related stigma in an onchocerciasis-endemic area in Mahenge, Tanzania: A pilot study

    Article • Epilepsy & Behavior, November 2021, Elsevier

    Prof Robert Colebunders

68. 
    “Slash and Clear”, a Community-Based Vector Control Method to Reduce Onchocerciasis Transmission by Simulium sirbanum in Maridi, South Sudan: A Prospective Study

    Article • Pathogens, October 2021, MDPI AG

    Prof Robert Colebunders

69. 
    Association Between Ov16 Seropositivity and Neurocognitive Performance Among Children in Rural Cameroon: a Pilot Study

    Article • Journal of Pediatric Neuropsychology, September 2021, Springer Science + Business Media

    Prof Robert Colebunders

70. 
    Ivermectin Should Not Be Recommended to Treat Severe Acute Respiratory Syndrome 2 Infection

    Article • Open Forum Infectious Diseases, September 2021, Oxford University Press (OUP)

    Prof Robert Colebunders

71. 
    ‘Slash and clear’ vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villages

    Article • BMJ Open, September 2021, BMJ

    Prof Robert Colebunders

72. 
    Epilepsy in the Sanaga‐Mbam valley, an onchocerciasis‐endemic region in Cameroon: electroclinical and neuropsychological findings

    Article • Epilepsia Open, August 2021, Wiley

    Prof Robert Colebunders

73. 
    COVID-19 Vaccine Acceptability and Its Determinants in Mozambique: An Online Survey

    Article • Vaccines, July 2021, MDPI AG

    Prof Robert Colebunders

74. 
    Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study

    Article • BMC Psychiatry, July 2021, Springer Science + Business Media

    Prof Robert Colebunders

75. 
    Stress and Associated Factors among Frontline Healthcare Workers in the COVID-19 Epicenter of Da Nang City, Vietnam

    Article • International Journal of Environmental Research and Public Health, July 2021, MDPI AG

    Prof Robert Colebunders

76. 
    No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy

    Article • Pathogens, July 2021, MDPI AG

    Prof Robert Colebunders

77. 
    Extensive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Associated With Low Mortality in Kinshasa, Democratic Republic of the Congo: For How Long?

    Article • Clinical Infectious Diseases, June 2021, Oxford University Press (OUP)

    Prof Robert Colebunders

78. 
    No Evidence Known Viruses Play a Role in the Pathogenesis of Onchocerciasis-Associated Epilepsy. An Explorative Metagenomic Case-Control Study

    Article • Pathogens, June 2021, MDPI AG

    Prof Robert Colebunders

79. 
    COVID-19 Vaccine Acceptance in Azuay Province, Ecuador: A Cross-Sectional Online Survey

    Article • Vaccines, June 2021, MDPI AG

    Prof Robert Colebunders

80. 
    First description of Nodding Syndrome in the Central African Republic

    Article • PLoS Neglected Tropical Diseases, June 2021, PLOS

    Prof Robert Colebunders

81. 
    Impact of COVID-19 on Healthcare Workers in Brazil between August and November 2020: A Cross-Sectional Survey

    Article • International Journal of Environmental Research and Public Health, June 2021, MDPI AG

    Prof Robert Colebunders

82. 
    Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study

    Article • Pathogens, June 2021, MDPI AG

    Prof Robert Colebunders

83. 
    COVID-19 Vaccine Acceptability and Adherence to Preventive Measures in Somalia: Results of an Online Survey

    Article • Vaccines, May 2021, MDPI AG

    Prof Robert Colebunders

84. 
    Stress and associated factors among frontline healthcare workers in the COVID-19 epicenter of Da Nang city, Vietnam

    Article • May 2021, Research Square

    Prof Robert Colebunders

85. 
    Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries

    Article • Vaccines, May 2021, MDPI AG

    Prof Robert Colebunders

86. 
    The World Health Organization road map for neglected tropical diseases 2021–2030: implications for onchocerciasis elimination programs

    Article • Infectious Diseases of Poverty, May 2021, Springer Science + Business Media

    Prof Robert Colebunders

87. 
    High Prevalence of Epilepsy in an Onchocerciasis-Endemic Area in Mvolo County, South Sudan: A Door-To-Door Survey

    Article • Pathogens, May 2021, MDPI AG

    Prof Robert Colebunders

88. 
    Intimate Partners Violence against Women during a COVID-19 Lockdown Period: Results of an Online Survey in 7 Provinces of the Democratic Republic of Congo

    Article • International Journal of Environmental Research and Public Health, May 2021, MDPI AG

    Prof Robert Colebunders

89. 
    Well-Being of Healthcare Workers and the General Public during the COVID-19 Pandemic in Vietnam: An Online Survey

    Article • International Journal of Environmental Research and Public Health, April 2021, MDPI AG

    Prof Robert Colebunders

90. 
    The Secretome of Filarial Nematodes and Its Role in Host-Parasite Interactions and Pathogenicity in Onchocerciasis-Associated Epilepsy

    Article • Frontiers in Cellular and Infection Microbiology, April 2021, Frontiers

    Prof Robert Colebunders

91. 
    Follow-Up Survey of the Impact of COVID-19 on People Living with HIV during the Second Semester of the Pandemic

    Article • International Journal of Environmental Research and Public Health, April 2021, MDPI AG

    Prof Robert Colebunders

92. 
    Seroprevalence of SARS-CoV-2 Infection and Adherence to Preventive Measures in Cuenca, Ecuador, October 2020, a Cross-Sectional Study

    Article • International Journal of Environmental Research and Public Health, April 2021, MDPI AG

    Prof Robert Colebunders

93. 
    COVID-19: The African Enigma

    Article • Colombia Medica, April 2021, Universidad del Valle

    Prof Robert Colebunders

94. 
    Prevalence of Onchocerciasis-Associated Epilepsy in Mvolo County, South Sudan: A Door to Door Survey

    Article • April 2021, MDPI AG

    Prof Robert Colebunders

95. 
    Vietnamese People’s Well-Being During the COVID-19 Pandemic: An Online Survey

    Article • March 2021, MDPI AG

    Prof Robert Colebunders

96. 
    Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study

    Article • Pathogens, March 2021, MDPI AG

    Prof Robert Colebunders

97. 
    Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo

    Article • Pathogens, March 2021, MDPI AG

    Prof Robert Colebunders

98. 
    Violence and discrimination among Ugandan residents during the COVID-19 lockdown

    Article • BMC Public Health, March 2021, Springer Science + Business Media

    Prof Robert Colebunders

99. 
    Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature

    Article • Pathogens, March 2021, MDPI AG

    Prof Robert Colebunders

100. 
     Adherence to COVID-19 Prevention Measures in the Democratic Republic of the Congo, Results of Two Consecutive Online Surveys

     Article • International Journal of Environmental Research and Public Health, March 2021, MDPI AG

     Prof Robert Colebunders

101. 
     COVID-19 Preventive Behaviours in Cameroon: A Six-Month Online National Survey

     Article • International Journal of Environmental Research and Public Health, March 2021, MDPI AG

     Prof Robert Colebunders

102. 
     Nodding syndrome research revisited

     Article • International Journal of Infectious Diseases, March 2021, Elsevier

     Prof Robert Colebunders

103. 
     Community perceptions and attitudes regarding epilepsy and disease cost after implementation of a community-based epilepsy treatment program in onchocerciasis-endemic communities in the Democratic Republic of Congo

     Article • Epilepsy & Behavior, March 2021, Elsevier

     Prof Robert Colebunders

104. 
     Impact of COVID-19 on the lives and psychosocial well-being of persons with epilepsy during the third trimester of the pandemic: Results from an international, online survey

     Article • Epilepsy & Behavior, March 2021, Elsevier

     Prof Robert Colebunders

105. 
     Determinants of Modern Contraceptive Methods (MCM) discontinuation among childbearing age women in Kinshasa, Democratic Republic of Congo.

     Article • February 2021, Research Square

     Prof Robert Colebunders

106. 
     In pursuit of a cure: The plural therapeutic landscape of onchocerciasis-associated epilepsy in Cameroon – A mixed methods study

     Article • PLoS Neglected Tropical Diseases, February 2021, PLOS

     Prof Robert Colebunders

107. 
     COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey

     Article • Vaccines, February 2021, MDPI AG

     Prof Robert Colebunders

108. 
     Fear and Depression during the COVID-19 Outbreak in Cameroon: A Nation-wide Observational Study

     Article • February 2021, Research Square

     Prof Robert Colebunders

109. 
     Adherence to COVID-19 Preventive Measures in Mozambique: Two Consecutive Online Surveys

     Article • International Journal of Environmental Research and Public Health, January 2021, MDPI AG

     Prof Robert Colebunders

110. 
     Neuropathological Changes in Nakalanga Syndrome—A Case Report

     Article • Pathogens, January 2021, MDPI AG

     Prof Robert Colebunders

111. 
     COVID-19 outbreak in Brazil: adherence to national preventive measures and impact on people’s lives, an online survey

     Article • BMC Public Health, January 2021, Springer Science + Business Media

     Prof Robert Colebunders

112. 
     Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation

     Article • PLoS Neglected Tropical Diseases, January 2021, PLOS

     Anne Laudisoit, Prof Robert Colebunders

113. 
     Adherence to COVID-19 Preventive Measures Prior to Vaccine Interventions: A Meta-Analysis of Online Surveys in Sub-Saharan Africa

     Article • SSRN Electronic Journal, January 2021, Elsevier

     Prof Robert Colebunders

114. 
     Assessment of adherence to public health measures and their impact on the COVID-19 outbreak in Benin Republic, West Africa

     Article • Pan African Medical Journal, January 2021, Pan African Medical Journal

     Prof Robert Colebunders

115. 
     Factors associated with adherence to COVID-19 prevention measures in the Democratic Republic of the Congo (DRC): results of an online survey

     Article • BMJ Open, January 2021, BMJ

     Prof Robert Colebunders

116. 
     Nodding syndrome, many questions remain but we can prevent it by eliminating onchocerciasis

     Article • Brain Communications, January 2021, Oxford University Press (OUP)

     Prof Robert Colebunders

117. 
     Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS

     Article • PLoS ONE, December 2020, PLOS

     Prof Robert Colebunders

118. 
     Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus

     Article • Pathogens, December 2020, MDPI AG

     Prof Robert Colebunders

119. 
     Case Report: Nakalanga Syndrome Revisited: Long-Term Follow-Up of a Patient Living in Western Uganda, 1994–2018

     Article • American Journal of Tropical Medicine and Hygiene, December 2020, American Society of Tropical Medicine and Hygiene

     Prof Robert Colebunders

120. 
     Ivermectin Treatment Response in Two Rural Villages with a High Prevalence of Onchocerciasis and Epilepsy, Mahenge Tanzania

     Article • December 2020, Research Square

     Prof Robert Colebunders

121. 
     Onchocerciasis-associated epilepsy an unrecognised important preventable public health problem

     Article • International Journal of Infectious Diseases, December 2020, Elsevier

     Prof Robert Colebunders

122. 
     Level and Determinants of Adherence to COVID-19 Preventive Measures in the First Stage of the Outbreak in Uganda

     Article • International Journal of Environmental Research and Public Health, November 2020, MDPI AG

     Prof Robert Colebunders

123. 
     Impact of the COVID-19 Pandemic on the Medical Follow-up and Psychosocial Well-Being of People Living With HIV: A Cross-Sectional Survey

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2020, Wolters Kluwer Health

     Prof Robert Colebunders

124. 
     Access to healthcare and prevalence of anxiety and depression in persons with epilepsy during the COVID-19 pandemic: A multicountry online survey

     Article • Epilepsy & Behavior, November 2020, Elsevier

     Prof Robert Colebunders

125. 
     Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies

     Article • The Lancet Infectious Diseases, November 2020, Elsevier

     Prof Robert Colebunders

126. 
     Improving mental health and psychosocial wellbeing in humanitarian settings: reflections on research funded through R2HC

     Article • Conflict and Health, October 2020, Springer Science + Business Media

     Prof Robert Colebunders

127. 
     OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study

     Article • Pathogens, October 2020, MDPI AG

     Prof Robert Colebunders

128. 
     Violence and Discrimination Among Ugandan Residents During the COVID-19 Lockdown

     Article • October 2020, Research Square

     Prof Robert Colebunders

129. 
     A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa

     Article • International Journal of Infectious Diseases, October 2020, Elsevier

     Prof Robert Colebunders

130. 
     Epilepsy-related stigma and cost in two onchocerciasis-endemic areas in South Sudan: A pilot descriptive study

     Article • Seizure, October 2020, Elsevier

     Prof Robert Colebunders

131. 
     Vietnamese People’s Well-Being During the COVID-19 Pandemic: An Online Survey

     Article • September 2020, Research Square

     Prof Robert Colebunders

132. 
     Vietnamese people’s well-being during the COVID-19 pandemic: an online survey 

     Article • September 2020, Research Square

     Prof Robert Colebunders

133. 
     Preventive behavior of Vietnamese people in response to the COVID-19 pandemic

     Article • PLoS ONE, September 2020, PLOS

     Prof Robert Colebunders

134. 
     COVID-19 in Somalia: Adherence to Preventive Measures and Evolution of the Disease Burden

     Article • Pathogens, September 2020, MDPI AG

     Prof Robert Colebunders

135. 
     Mass masking as a way to contain COVID-19 and exit lockdown in low- and middle-income countries

     Article • Journal of Infection, September 2020, Elsevier

     Prof Robert Colebunders

136. 
     Evidence for significant COVID-19 community transmission in Somalia using a clinical case definition

     Article • International Journal of Infectious Diseases, September 2020, Elsevier

     Prof Robert Colebunders

137. 
     Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study

     Article • Pathogens, July 2020, MDPI AG

     Prof Robert Colebunders

138. 
     COVID-19 outbreak in Brazil: Adherence to national preventive measures and impact on people’s lives

     Article • July 2020, Research Square

     Prof Robert Colebunders

139. 
     Le français innovant

     Article • June 2020, Peter Lang, International Academic Publishers

     Prof Robert Colebunders

140. 
     Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo

     Article • Pathogens, June 2020, MDPI AG

     Prof Robert Colebunders

141. 
     Dried Blood Microsampling-Based Therapeutic Drug Monitoring of Antiepileptic Drugs in Children With Nodding Syndrome and Epilepsy in Uganda and the Democratic Republic of the Congo

     Article • Therapeutic Drug Monitoring, June 2020, Wolters Kluwer Health

     Christophe Stove, Prof Robert Colebunders

142. 
     Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection

     Article • Epileptic Disorders, June 2020, Wiley

     Prof Robert Colebunders

143. 
     Preventive behavior of Vietnamese people in response to the COVID-19 pandemic

     Article • May 2020, Cold Spring Harbor Laboratory Press

     Prof Robert Colebunders

144. 
     From nodding syndrome to onchocerciasis-associated epilepsy

     Article • Revue Neurologique, May 2020, Elsevier

     Prof Robert Colebunders

145. 
     Focus of Ongoing Onchocerciasis Transmission Close to Bangui, Central African Republic

     Article • Pathogens, April 2020, MDPI AG

     Prof Robert Colebunders

146. 
     The Role of the Maridi Dam in Causing an Onchocerciasis-Associated Epilepsy Epidemic in Maridi, South Sudan: An Epidemiological, Sociological, and Entomological Study

     Article • Pathogens, April 2020, MDPI AG

     Prof Robert Colebunders

147. 
     Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali

     Article • Clinical Infectious Diseases, March 2020, Oxford University Press (OUP)

     Prof Robert Colebunders

148. 
     Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo

     Article • Pathogens, March 2020, MDPI AG

     Prof Robert Colebunders

149. 
     Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control

     Article • International Health, March 2020, Oxford University Press (OUP)

     Prof Robert Colebunders

150. 
     Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy

     Article • Pathogens, March 2020, MDPI AG

     Prof Robert Colebunders

151. 
     Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures

     Article • Infectious Diseases of Poverty, March 2020, Springer Science + Business Media

     Prof Robert Colebunders

152. 
     Safety of ivermectin during pregnancy

     Article • The Lancet Global Health, March 2020, Elsevier

     Prof Robert Colebunders

153. 
     Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy

     Article • International Journal of Infectious Diseases, February 2020, Elsevier

     Prof Robert Colebunders

154. 
     Single Versus Multiple Dose Ivermectin Regimen in Onchocerciasis-infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo

     Article • January 2020, MDPI AG

     Prof Robert Colebunders

155. 
     Lymphedema in three previously Wuchereria bancrofti-endemic health districts in Mali after cessation of mass drug administration

     Article • BMC Infectious Diseases, January 2020, Springer Science + Business Media

     Prof Robert Colebunders

156. 
     Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial

     Article • PLoS Neglected Tropical Diseases, January 2020, PLOS

     Anne Laudisoit, Prof Robert Colebunders

157. 
     Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programmes

     Article • British Journal of Dermatology, December 2019, Wiley

     Prof Robert Colebunders

158. 
     Epilepsy prevention

     Article • The Lancet, December 2019, Elsevier

     Prof Robert Colebunders

159. 
     Nodding Syndrome

     Article • The Pediatric Infectious Disease Journal, November 2019, Wolters Kluwer Health

     Prof Robert Colebunders

160. 
     Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions

     Article • Infectious Diseases of Poverty, October 2019, Springer Science + Business Media

     Prof Robert Colebunders

161. 
     Women with epilepsy in sub–Saharan Africa: A review of the reproductive health challenges and perspectives for management

     Article • Seizure, October 2019, Elsevier

     Prof Robert Colebunders

162. 
     Clinical presentation of epilepsy in six villages in an onchocerciasis endemic area in Mahenge, Tanzania

     Article • Epileptic Disorders, October 2019, Wiley

     Prof Robert Colebunders

163. 
     Emergomyces: The global rise of new dimorphic fungal pathogens

     Article • PLoS Pathogens, September 2019, PLOS

     Prof Robert Colebunders

164. 
     Neuroinflammation and Not Tauopathy Is a Predominant Pathological Signature of Nodding Syndrome

     Article • Journal of Neuropathology & Experimental Neurology, September 2019, Oxford University Press (OUP)

     Prof Robert Colebunders

165. 
     Analysis of the RIMDAMAL trial

     Article • The Lancet, September 2019, Elsevier

     Prof Robert Colebunders

166. 
     Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?

     Article • Infectious Diseases of Poverty, August 2019, Springer Science + Business Media

     Prof Robert Colebunders

167. 
     Increased cost‐benefit of strengthening onchocerciasis elimination efforts in areas with high onchocerciasis‐associated epilepsy

     Article • Tropical Medicine & International Health, August 2019, Wiley

     Prof Robert Colebunders

168. 
     The efficacy of a brief intervention to reduce alcohol use in persons with HIV in South Africa, a randomized clinical trial

     Article • PLoS ONE, August 2019, PLOS

     Diana Huis in 't Veld, Prof Robert Colebunders

169. 
     From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes

     Article • PLoS Neglected Tropical Diseases, July 2019, PLOS

     Anne Laudisoit, Prof Robert Colebunders

170. 
     Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density

     Article • PLoS Neglected Tropical Diseases, July 2019, PLOS

     Prof Robert Colebunders

171. 
     Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa

     Article • International Health, June 2019, Oxford University Press (OUP)

     Prof Robert Colebunders

172. 
     Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania

     Article • Infectious Diseases of Poverty, May 2019, Springer Science + Business Media

     Prof Robert Colebunders

173. 
     Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group

     Article • Infectious Diseases of Poverty, May 2019, Springer Science + Business Media

     Prof Robert Colebunders

174. 
     Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index

     Article • Health and Quality of Life Outcomes, May 2019, Springer Science + Business Media

     Prof Robert Colebunders

175. 
     Epidemiological evidence concerning the association between onchocerciasis and epilepsy

     Article • International Journal of Infectious Diseases, May 2019, Elsevier

     Prof Robert Colebunders

176. 
     Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS

     Article • PLoS ONE, April 2019, PLOS

     Prof Robert Colebunders

177. 
     New filovirus disease classification and nomenclature

     Article • Nature Reviews Microbiology, March 2019, Springer Science + Business Media

     Prof Robert Colebunders, Dr Jens H. Kuhn

178. 
     Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon

     Article • Parasites & Vectors, March 2019, Springer Science + Business Media

     Prof Robert Colebunders

179. 
     Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density

     Article • March 2019, Cold Spring Harbor Laboratory Press

     Prof Robert Colebunders

180. 
     Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo

     Article • EClinicalMedicine, March 2019, Elsevier

     Prof Robert Colebunders

181. 
     Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys

     Article • Infectious Diseases of Poverty, February 2019, Springer Science + Business Media

     Prof Robert Colebunders

182. 
     High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment

     Article • International Journal of Infectious Diseases, February 2019, Elsevier

     Prof Robert Colebunders

183. 
     Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test

     Article • PLoS Neglected Tropical Diseases, January 2019, PLOS

     Prof Robert Colebunders

184. 
     Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria

     Article • Infectious Diseases of Poverty, January 2019, Springer Science + Business Media

     Prof Robert Colebunders

185. 
     Nodding syndrome research, lessons learned from the NSETHIO project

     Article • Cambridge Prisms Global Mental Health, January 2019, Cambridge University Press

     Prof Robert Colebunders

186. 
     Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon

     Article • Epilepsy & Behavior, January 2019, Elsevier

     Prof Robert Colebunders

187. 
     Intervention for reducing epilepsy-associated stigma

     Article • Epilepsy & Behavior, January 2019, Elsevier

     Prof Robert Colebunders

188. 
     The Effect of Onchocerciasis Elimination on Onchocerciasis-Associated Epilepsy in a Hyper-Endemic Focus of Western Uganda

     Article • SSRN Electronic Journal, January 2019, Elsevier

     Prof Robert Colebunders

189. 
     Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2018, Wolters Kluwer Health

     Prof Robert Colebunders

190. 
     Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo

     Article • Infectious Diseases of Poverty, December 2018, Springer Science + Business Media

     Prof Robert Colebunders

191. 
     Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin

     Article • Infectious Diseases of Poverty, December 2018, Springer Science + Business Media

     Prof Robert Colebunders

192. 
     High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey

     Article • Seizure, December 2018, Elsevier

     Prof Robert Colebunders

193. 
     Oral Tecovirimat for the Treatment of Smallpox

     Article • New England Journal of Medicine, November 2018, New England Journal of Medicine (NEJM/MMS)

     Prof Robert Colebunders

194. 
     Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS

     Article • New England Journal of Medicine, November 2018, New England Journal of Medicine (NEJM/MMS)

     Lut Lynen, Prof Robert Colebunders

195. 
     The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol

     Article • Infectious Diseases of Poverty, November 2018, Springer Science + Business Media

     Prof Robert Colebunders

196. 
     Factors Influencing the Risk of Becoming Sexually Active Among HIV Infected Adolescents in Kampala and Kisumu, East Africa

     Article • AIDS and Behavior, November 2018, Springer Science + Business Media

     Prof Robert Colebunders

197. 
     Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan

     Article • Seizure, November 2018, Elsevier

     Prof Robert Colebunders

198. 
     The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study

     Article • The Lancet Infectious Diseases, November 2018, Elsevier

     Prof Robert Colebunders

199. 
     Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study

     Article • Infectious Diseases of Poverty, October 2018, Springer Science + Business Media

     Prof Robert Colebunders

200. 
     Is nodding syndrome in northern Uganda linked to consumption of mycotoxin contaminated food grains?

     Article • BMC Research Notes, September 2018, Springer Science + Business Media

     Prof Robert Colebunders

201. 
     Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV–tuberculosis co-infected adults with low CD4+ cell counts

     Article • AIDS, September 2018, Wolters Kluwer Health

     Prof Robert Colebunders

202. 
     Burden of onchocerciasis-associated epilepsy: first estimates and research priorities

     Article • Infectious Diseases of Poverty, September 2018, Springer Science + Business Media

     Prof Robert Colebunders

203. 
     Aberrant plasma MMP and TIMP dynamics in Schistosoma - Immune reconstitution inflammatory syndrome (IRIS)

     Article • PLoS Neglected Tropical Diseases, August 2018, PLOS

     Prof Robert Colebunders

204. 
     High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo

     Article • Infectious Diseases of Poverty, August 2018, Springer Science + Business Media

     Prof Robert Colebunders

205. 
     Onchocerciasis associated epilepsy: An important neglected public health problem

     Article • Seizure, August 2018, Elsevier

     Prof Robert Colebunders

206. 
     Epilepsy caused by onchocerciasis is an important public health problem in Africa

     Article • International Journal of Infectious Diseases, August 2018, Elsevier

     Prof Robert Colebunders

207. 
     High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin

     Article • Infectious Diseases of Poverty, June 2018, Springer Science + Business Media

     Prof Robert Colebunders

208. 
     Factors Associated with Wuchereria bancrofti Microfilaremia in an Endemic Area of Mali

     Article • American Journal of Tropical Medicine and Hygiene, June 2018, American Society of Tropical Medicine and Hygiene

     Prof Robert Colebunders

209. 
     The blackfly vectors and transmission of Onchocerca volvulus in Mahenge, south eastern Tanzania

     Article • Acta Tropica, May 2018, Elsevier

     Prof Robert Colebunders

210. 
     Synergistic Impact of Training Followed by On-Site Support on HIV Clinical Practice: A Mixed-Design Study in Uganda With Pre/Post and Cluster-Randomized Trial Components

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2018, Wolters Kluwer Health

     Prof Robert Colebunders

211. 
     Histological examination of post-mortem brains of children with nodding syndrome

     Article • Annals of Translational Medicine, April 2018, AME Publishing Company

     Prof Robert Colebunders

212. 
     Considerations for Randomized Controlled Trials During Future Filovirus Outbreaks

     Article • Clinical Infectious Diseases, March 2018, Oxford University Press (OUP)

     Prof Robert Colebunders

213. 
     From river blindness control to elimination: bridge over troubled water

     Article • Infectious Diseases of Poverty, March 2018, Springer Science + Business Media

     Prof Robert Colebunders

214. 
     Report of the first international workshop on onchocerciasis-associated epilepsy

     Article • Infectious Diseases of Poverty, March 2018, Springer Science + Business Media

     Prof Robert Colebunders

215. 
     Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years

     Article • BMJ Open, March 2018, BMJ

     Prof Robert Colebunders

216. 
     Molecular tests expedite the diagnosis of multidrug-resistant tuberculosis in childhood

     Article • The International Journal of Tuberculosis and Lung Disease, March 2018, International Union Against Tuberculosis and Lung Disease

     Prof Robert Colebunders

217. 
     Onchocerciasis-Associated Epilepsy, an Additional Reason for Strengthening Onchocerciasis Elimination Programs

     Article • Trends in Parasitology, March 2018, Elsevier

     Prof Robert Colebunders

218. 
     Emergomyces africanus in Soil, South Africa

     Article • Emerging Infectious Diseases, February 2018, Centers for Disease Control and Prevention (CDC)

     Prof Robert Colebunders

219. 
     Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2018, Wolters Kluwer Health

     Prof Robert Colebunders

220. 
     Molecular detection of airborne Emergomyces africanus, a thermally dimorphic fungal pathogen, in Cape Town, South Africa

     Article • PLoS Neglected Tropical Diseases, January 2018, PLOS

     Prof Robert Colebunders

221. 
     Elevated inflammatory cytokines in aqueous cytokine profile in HIV-1 infected patients with cataracts in Uganda

     Article • BMC Ophthalmology, January 2018, Springer Science + Business Media

     Prof Robert Colebunders

222. 
     Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda

     Article • International Health, January 2018, Oxford University Press (OUP)

     Prof Robert Colebunders

223. 
     Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

     Article • The Lancet Infectious Diseases, January 2018, Elsevier

     Prof Robert Colebunders

224. 
     High Prevalence of Onchocerciasis-Associated Epilepsy in Villages in Maridi County, Republic of South Sudan

     Article • SSRN Electronic Journal, January 2018, Elsevier

     Prof Robert Colebunders

225. 
     High mortality in non-Ebola virus disease cases: need to provide timely and effective care

     Article • The Lancet Infectious Diseases, October 2017, Elsevier

     Prof Robert Colebunders

226. 
     Attempted molecular detection of the thermally dimorphic human fungal pathogen Emergomyces africanus in terrestrial small mammals in South Africa

     Article • Medical Mycology, September 2017, Oxford University Press (OUP)

     Prof Robert Colebunders

227. 
     Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial

     Article • JMIR Research Protocols, August 2017, JMIR Publications Inc.

     Prof Robert Colebunders

228. 
     Significant rates of risky sexual behaviours among HIV-infected patients failing first-line ART: A sub-study of the Europe–Africa Research Network for the Evaluation of Second-line Therapy trial

     Article • International Journal of STD & AIDS, August 2017, SAGE Publications

     Prof Robert Colebunders

229. 
     Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

     Article • The Lancet HIV, August 2017, Elsevier

     Prof Robert Colebunders

230. 
     The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study

     Article • Clinical Infectious Diseases, July 2017, Oxford University Press (OUP)

     Prof Robert Colebunders

231. 
     High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo

     Article • PLoS Neglected Tropical Diseases, July 2017, PLOS

     Prof Robert Colebunders

232. 
     The predicament of patients with suspected Ebola

     Article • The Lancet Global Health, July 2017, Elsevier

     Prof Robert Colebunders

233. 
     Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study

     Article • BMC Infectious Diseases, June 2017, Springer Science + Business Media

     Prof Robert Colebunders

234. 
     Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia

     Article • PLoS ONE, June 2017, PLOS

     Lut Lynen, Prof Robert Colebunders

235. 
     Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment — 10 Countries, 2004–2015

     Article • MMWR Morbidity and Mortality Weekly Report, June 2017, Centers for Disease Control MMWR Office

     Prof Robert Colebunders

236. 
     Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda

     Article • Vaccine, May 2017, Elsevier

     Prof Robert Colebunders

237. 
     Onchocerciasis-associated epilepsy: From recent epidemiological and clinical findings to policy implications

     Article • Epilepsia Open, April 2017, Wiley

     Prof Robert Colebunders

238. 
     First HIV prevalence estimates of a representative sample of adult sub-Saharan African migrants in a European city. Results of a community-based, cross-sectional study in Antwerp, Belgium

     Article • PLoS ONE, April 2017, PLOS

     Prof Robert Colebunders

239. 
     Relationship Between Time to Initiation of Antiretroviral Therapy and Treatment Outcomes: A Cohort Analysis of ART Eligible Adolescents in Zimbabwe

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2017, Wolters Kluwer Health

     Prof Robert Colebunders

240. 
     Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys

     Article • International Health, March 2017, Oxford University Press (OUP)

     Prof Robert Colebunders

241. 
     Body Mass Index and Waist Circumference in Patients with HIV in South Africa and Associated Socio-demographic, Health Related and Psychosocial Factors

     Article • AIDS and Behavior, February 2017, Springer Science + Business Media

     Diana Huis in 't Veld, Prof Robert Colebunders

242. 
     Nodding syndrome: Preventable and treatable

     Article • Science Translational Medicine, February 2017, American Association for the Advancement of Science

     Prof Robert Colebunders

243. 
     Persons living with HIV infection on antiretroviral therapy also consulting traditional healers: a study in three African countries

     Article • International Journal of STD & AIDS, February 2017, SAGE Publications

     Jane Wanyama, Prof Robert Colebunders

244. 
     AIDS-Related Endemic Mycoses in Western Cape, South Africa, and Clinical Mimics: A Cross-Sectional Study of Adults With Advanced HIV and Recent-Onset, Widespread Skin Lesions

     Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

     Prof Robert Colebunders

245. 
     Nodding syndrome, other forms of epilepsy, and the Nakalanga syndrome most likely directly or indirectly caused by Onchocerca volvulus

     Article • Journal of the Neurological Sciences, January 2017, Elsevier

     Prof Robert Colebunders

246. 
     Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial

     Article • American Journal of Tropical Medicine and Hygiene, December 2016, American Society of Tropical Medicine and Hygiene

     Dr Frank van Leth, Prof Robert Colebunders

247. 
     Weight status and associated factors among HIV infected people on antiretroviral therapy in rural Dikgale, Limpopo, South Africa

     Article • African Journal of Primary Health Care & Family Medicine, November 2016, AOSIS Open Journals

     Prof Robert Colebunders

248. 
     Is Plasmodium Species Parasitemia Really Associated With Increased Survival in Ebola Virus–Infected Patients?

     Article • Clinical Infectious Diseases, November 2016, Oxford University Press (OUP)

     Prof Robert Colebunders

249. 
     PrEP for African migrants in Europe? A research agenda

     Article • The Lancet HIV, November 2016, Elsevier

     Prof Robert Colebunders

250. 
     Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa

     Article • AIDS and Behavior, October 2016, Springer Science + Business Media

     Prof Robert Colebunders

251. 
     Overlooking the importance of immunoassays – Authors' reply

     Article • The Lancet Infectious Diseases, October 2016, Elsevier

     Prof Robert Colebunders, Dr Jens H. Kuhn

252. 
     Effect of On-Site Support on Laboratory Practice for Human Immunodeficiency Virus, Tuberculosis, and Malaria Testing

     Article • American Journal of Clinical Pathology, September 2016, Oxford University Press (OUP)

     Prof Robert Colebunders

253. 
     Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

     Article • JMIR Research Protocols, August 2016, JMIR Publications Inc.

     Lut Lynen, Prof Robert Colebunders

254. 
     Effectiveness of educational outreach in infectious diseases management: a cluster randomized trial in Uganda

     Article • BMC Public Health, August 2016, Springer Science + Business Media

     Prof Robert Colebunders

255. 
     Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case–control study

     Article • International Journal of Infectious Diseases, August 2016, Elsevier

     Dr Kenneth M. Pfarr, Prof Robert Colebunders

256. 
     Nodding Syndrome in Onchocerciasis Endemic Areas

     Article • Trends in Parasitology, August 2016, Elsevier

     Prof Robert Colebunders

257. 
     Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

     Article • Journal of the International AIDS Society, July 2016, Wiley

     Prof Robert Colebunders

258. 
     High-risk alcohol use and associated socio-demographic, health and psychosocial factors in patients with HIV infection in three primary health care clinics in South Africa

     Article • International Journal of STD & AIDS, July 2016, SAGE Publications

     Diana Huis in 't Veld, Prof Robert Colebunders

259. 
     Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2016, Wolters Kluwer Health

     Prof Robert Colebunders

260. 
     Essentials of filoviral load quantification

     Article • The Lancet Infectious Diseases, July 2016, Elsevier

     Prof Robert Colebunders, Dr Jens H. Kuhn

261. 
     Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo

     Article • PLoS Neglected Tropical Diseases, May 2016, PLOS

     Prof Robert Colebunders

262. 
     Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda

     Article • BMC Research Notes, March 2016, Springer Science + Business Media

     Prof Robert Colebunders

263. 
     TOGETHER Project to Increase Understanding of the HIV Epidemic Among Sub-Saharan African Migrants: Protocol of Community-Based Participatory Mixed-Method Studies

     Article • JMIR Research Protocols, March 2016, JMIR Publications Inc.

     Prof Robert Colebunders

264. 
     Implementation and Operational Research

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2016, Wolters Kluwer Health

     Prof Robert Colebunders

265. 
     Nodding syndrome—we can now prevent it

     Article • International Journal of Infectious Diseases, March 2016, Elsevier

     Prof Robert Colebunders

266. 
     Reasons for Missing Antiretroviral Therapy: Results from a Multi-Country Study in Tanzania, Uganda, and Zambia

     Article • PLoS ONE, January 2016, PLOS

     Prof Robert Colebunders

267. 
     Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

     Article • New England Journal of Medicine, January 2016, New England Journal of Medicine (NEJM/MMS)

     Lut Lynen, Prof Robert Colebunders

268. 
     Reply to “A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis”

     Article • Journal of Clinical Microbiology, January 2016, ASM Journals

     Prof Robert Colebunders

269. 
     Temporal trends in death causes in adults attending an urban HIV clinic in Uganda: a retrospective chart review

     Article • BMJ Open, January 2016, BMJ

     Prof Robert Colebunders

270. 
     A Critical Appraisal of the Ideology of Monogamy’s Influence on HIV Epidemiology

     Article • World Journal of AIDS, January 2016, Scientific Research Publishing, Inc,

     Prof Robert Colebunders

271. 
     Systematic screening for drug-resistant tuberculosis with Xpert® MTB/RIF in a referral hospital in Cambodia

     Article • The International Journal of Tuberculosis and Lung Disease, December 2015, International Union Against Tuberculosis and Lung Disease

     Lut Lynen, Prof Robert Colebunders

272. 
     Assessment of cardiovascular risk factors in people with HIV infection treated with ART in rural South Africa: a cross sectional study

     Article • AIDS Research and Therapy, December 2015, Springer Science + Business Media

     Prof Robert Colebunders

273. 
     Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women — 12 Countries, 2002–2013

     Article • MMWR Morbidity and Mortality Weekly Report, November 2015, Centers for Disease Control MMWR Office

     Prof Robert Colebunders

274. 
     Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study

     Article • PLoS Neglected Tropical Diseases, October 2015, PLOS

     Lut Lynen, Prof Robert Colebunders

275. 
     Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2015, Wolters Kluwer Health

     Diana Huis in 't Veld, Prof Robert Colebunders

276. 
     Effect of Educational Outreach Timing and Duration on Facility Performance for Infectious Disease Care in Uganda: A Trial with Pre-Post and Cluster Randomized Controlled Components

     Article • PLoS ONE, September 2015, PLOS

     Prof Robert Colebunders

277. 
     Nodding Syndrome May Be Only the Ears of the Hippo

     Article • PLoS Neglected Tropical Diseases, August 2015, PLOS

     Prof Robert Colebunders

278. 
     The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field

     Article • Clinical Infectious Diseases, August 2015, Oxford University Press (OUP)

     Lut Lynen, Prof Robert Colebunders

279. 
     Challenges from Tuberculosis Diagnosis to Care in Community-Based Active Case Finding among the Urban Poor in Cambodia: A Mixed-Methods Study

     Article • PLoS ONE, July 2015, PLOS

     Lut Lynen, Prof Robert Colebunders

280. 
     Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

     Article • HIV Medicine, July 2015, Wiley

     Dr. Vicente Soriano, Prof Robert Colebunders

281. 
     Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome

     Article • PLoS ONE, July 2015, PLOS

     Prof Robert Colebunders

282. 
     Accuracy of Lipoarabinomannan and Xpert MTB/RIF Testing in Cerebrospinal Fluid To Diagnose Tuberculous Meningitis in an Autopsy Cohort of HIV-Infected Adults

     Article • Journal of Clinical Microbiology, June 2015, ASM Journals

     Prof Robert Colebunders

283. 
     Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case Series

     Article • Clinical Infectious Diseases, June 2015, Oxford University Press (OUP)

     Prof Robert Colebunders

284. 
     Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda

     Article • BMC Health Services Research, June 2015, Springer Science + Business Media

     Prof Robert Colebunders

285. 
     Behaviour, not mobility, is a risk factor for HIV

     Article • The Lancet HIV, June 2015, Elsevier

     Prof Robert Colebunders

286. 
     La dia-variation en français actuel

     Article • May 2015, Peter Lang, International Academic Publishers

     Prof Robert Colebunders

287. 
     Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults

     Article • PLoS ONE, April 2015, PLOS

     Prof Robert Colebunders

288. 
     Malaria Care in Infants Aged under Six Months in Uganda: An Area of Unmet Needs!

     Article • PLoS ONE, April 2015, PLOS

     Prof Robert Colebunders

289. 
     Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2015, Wolters Kluwer Health

     Dr. Vicente Soriano, Prof Robert Colebunders

290. 
     Filovirus epidemic in 1956 in Bili, DRC

     Article • The Lancet Infectious Diseases, April 2015, Elsevier

     Prof Robert Colebunders

291. 
     Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

     Article • PLoS Medicine, March 2015, PLOS

     Dr Alejandro J Krolewiecki, Dr. Vicente Soriano, Lut Lynen, Hugh Montgomery, Prof Robert Colebunders

292. 
     Large-scale Convalescent Blood and Plasma Transfusion Therapy for Ebola Virus Disease

     Article • The Journal of Infectious Diseases, January 2015, Oxford University Press (OUP)

     Prof Robert Colebunders

293. 
     Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia

     Article • AIDS, January 2015, Wolters Kluwer Health

     Prof Robert Colebunders

294. 
     Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient

     Article • Eurosurveillance, January 2015, European Centre for Disease Control and Prevention (ECDC)

     Prof Robert Colebunders

295. 
     Is frontloaded sputum microscopy an option in active tuberculosis case finding?

     Article • The International Journal of Tuberculosis and Lung Disease, January 2015, International Union Against Tuberculosis and Lung Disease

     Lut Lynen, Prof Robert Colebunders

296. 
     Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings

     Article • The Lancet Infectious Diseases, January 2015, Elsevier

     Lut Lynen, Prof Robert Colebunders

297. 
     Correlates of concurrency among young people in Carletonville, South Africa

     Article • SAHARA-J Journal of Social Aspects of HIV/AIDS, January 2015, Taylor & Francis

     Prof Robert Colebunders

298. 
     Antiretroviral Treatment Program Retention among HIV-Infected Children in the Democratic Republic of Congo

     Article • PLoS ONE, December 2014, PLOS

     Prof Robert Colebunders

299. 
     Practice of percutaneous needle autopsy; a descriptive study reporting experiences from Uganda

     Article • BMC Clinical Pathology, December 2014, Springer Science + Business Media

     Prof Robert Colebunders

300. 
     Antigen-Specific Interferon-Gamma Responses and Innate Cytokine Balance in TB-IRIS

     Article • PLoS ONE, November 2014, PLOS

     Prof Robert Colebunders

301. 
     Nodding syndrome since 2012: recent progress, challenges and recommendations for future research

     Article • Tropical Medicine & International Health, November 2014, Wiley

     Prof Robert Colebunders

302. 
     Priorities for Ebola virus disease response in west Africa

     Article • The Lancet, November 2014, Elsevier

     John schieffelin, Prof Robert Colebunders

303. 
     Disease diagnosis in primary care in Uganda

     Article • BMC Family Practice, October 2014, Springer Science + Business Media

     Prof Robert Colebunders

304. 
     Cost-Effectiveness of Socioeconomic Support as Part of HIV Care for the Poor in an Urban Community-Based Antiretroviral Program in Uganda

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2014, Wolters Kluwer Health

     Prof Robert Colebunders

305. 
     Needle Autopsy to Establish the Cause of Death in HIV-Infected Hospitalized Adults in Uganda

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2014, Wolters Kluwer Health

     Prof Robert Colebunders

306. 
     Nodding syndrome—a new hypothesis and new direction for research

     Article • International Journal of Infectious Diseases, October 2014, Elsevier

     Prof Robert Colebunders

307. 
     Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia

     Article • Tropical Medicine & International Health, September 2014, Wiley

     Prof Robert Colebunders

308. 
     Concentration of Lymph Node Aspirate Improves the Sensitivity of Acid Fast Smear Microscopy for the Diagnosis of Tuberculous Lymphadenitis in Jimma, Southwest Ethiopia

     Article • PLoS ONE, September 2014, PLOS

     Prof Robert Colebunders, Prof Gemeda Abebe

309. 
     CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda

     Article • Immunology Letters, September 2014, Elsevier

     Prof Robert Colebunders

310. 
     Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

     Article • New England Journal of Medicine, July 2014, New England Journal of Medicine (NEJM/MMS)

     Prof Robert Colebunders

311. 
     Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

     Article • The Lancet, July 2014, Elsevier

     Dr. Vicente Soriano, Prof Robert Colebunders

312. 
     Migration intensity has no effect on peak HIV prevalence: an ecological study

     Article • BMC Infectious Diseases, June 2014, Springer Science + Business Media

     Prof Robert Colebunders

313. 
     Delays in diagnosis and treatment of pulmonary tuberculosis in Wakiso and Mukono districts, Uganda

     Article • BMC Public Health, June 2014, Springer Science + Business Media

     Prof Robert Colebunders

314. 
     A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population

     Article • BMC Infectious Diseases, June 2014, Springer Science + Business Media

     Prof Robert Colebunders

315. 
     A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

     Article • Infection, June 2014, Springer Science + Business Media

     Dr. Vicente Soriano, Prof Robert Colebunders

316. 
     Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation

     Article • Journal of the American Heart Association, May 2014, Wolters Kluwer Health

     Prof Robert Colebunders

317. 
     Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

     Article • HIV Medicine, May 2014, Wiley

     Dr. Vicente Soriano, Prof Robert Colebunders

318. 
     Cardiovascular risk factors in a treatment-naïve, human immunodeficiency virus-infected rural population in Dikgale, South Africa

     Article • South African Family Practice, May 2014, AOSIS Open Journals

     Prof Robert Colebunders

319. 
     Early Tracking after a Missed Return Visit Reduces the Proportion of Untraceable Patients at a Large HIV Clinic in Kampala, Uganda

     Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), April 2014, SAGE Publications

     Prof Robert Colebunders

320. 
     Two year mortality and associated factors in a cohort of children from rural Uganda

     Article • BMC Public Health, April 2014, Springer Science + Business Media

     Prof Robert Colebunders

321. 
     Community-Based Active Tuberculosis Case Finding in Poor Urban Settlements of Phnom Penh, Cambodia: A Feasible and Effective Strategy

     Article • PLoS ONE, March 2014, PLOS

     Lut Lynen, Prof Robert Colebunders

322. 
     Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study

     Article • BMC Nephrology, March 2014, Springer Science + Business Media

     Dr. Vicente Soriano, Prof Robert Colebunders

323. 
     Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic, Uganda

     Article • International Journal of STD & AIDS, March 2014, SAGE Publications

     Prof Robert Colebunders

324. 
     Health Outcomes of Infants in a PMTCT Program in Kinshasa

     Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), March 2014, SAGE Publications

     Prof Robert Colebunders

325. 
     Deteriorating renal function and clinical outcomes in HIV-positive persons

     Article • AIDS, March 2014, Wolters Kluwer Health

     Dr. Vicente Soriano, Prof Robert Colebunders

326. 
     Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe

     Article • PLoS ONE, January 2014, PLOS

     Dr. Vicente Soriano, Prof Robert Colebunders

327. 
     Effect of Integrated Capacity-Building Interventions on Malaria Case Management by Health Professionals in Uganda: A Mixed Design Study with Pre/Post and Cluster Randomized Trial Components

     Article • PLoS ONE, January 2014, PLOS

     Prof Robert Colebunders

328. 
     The Association between Female Genital Cutting and Spousal HCV Infection in Egypt

     Article • International Journal of Hepatology, January 2014, Hindawi Publishing Corporation

     Prof Robert Colebunders

329. 
     The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome

     Article • Immunobiology, January 2014, Elsevier

     Prof Robert Colebunders

330. 
     LPS-Binding Protein and IL-6 Mark Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome in HIV Patients

     Article • PLoS ONE, November 2013, PLOS

     Prof Robert Colebunders

331. 
     Does the CHER trial open up new therapeutic perspectives?

     Article • The Lancet, November 2013, Elsevier

     Prof Robert Colebunders

332. 
     Increase in numbers and proportions of review articles in Tropical Medicine, Infectious Diseases, and oncology

     Article • Journal of the Association for Information Science and Technology, October 2013, Wiley

     Prof Robert Colebunders

333. 
     Evaluation of the 2007 WHO guideline to diagnose smear negative tuberculosis in an urban hospital in Ethiopia

     Article • BMC Infectious Diseases, September 2013, Springer Science + Business Media

     Prof Robert Colebunders, Prof Gemeda Abebe

334. 
     Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia

     Article • Journal of the International Association of Physicians in AIDS Care, August 2013, SAGE Publications

     Prof. Mirkuzie Woldie, Prof Robert Colebunders

335. 
     Acceptability of HIV self-testing: a systematic literature review

     Article • BMC Public Health, August 2013, Springer Science + Business Media

     Prof Robert Colebunders

336. 
     Implementation of tuberculosis infection control in health facilities in Mukono and Wakiso districts, Uganda

     Article • BMC Infectious Diseases, August 2013, Springer Science + Business Media

     Prof Robert Colebunders

337. 
     Burden of tuberculosis disease among adolescents in a rural cohort in Eastern Uganda

     Article • BMC Infectious Diseases, July 2013, Springer Science + Business Media

     Willy SSENGOOBA, Prof Robert Colebunders

338. 
     Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda

     Article • International Journal of STD & AIDS, July 2013, SAGE Publications

     Prof Robert Colebunders

339. 
     Partner-concurrency associated with herpes simplex virus 2 infection in young South Africans

     Article • International Journal of STD & AIDS, July 2013, SAGE Publications

     Prof Robert Colebunders

340. 
     Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome

     Article • AIDS, July 2013, Wolters Kluwer Health

     Prof Robert Colebunders

341. 
     THE IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME: A CAUSE OF DEATH IN PERSONS ON ANTIRETROVIRAL THERAPY?

     Article • Acta Clinica Belgica, July 2013, Peeters Publishers

     Diana Huis in 't Veld, Martin Lammens, Prof Robert Colebunders

342. 
     Antiretrovirals During Pregnancy: A Note of Caution

     Article • The Journal of Infectious Diseases, May 2013, Oxford University Press (OUP)

     Prof Robert Colebunders

343. 
     Determinants of generalized herpes simplex virus-2 epidemics: the role of sexual partner concurrency

     Article • International Journal of STD & AIDS, May 2013, SAGE Publications

     Prof Robert Colebunders

344. 
     Peak HIV prevalence: a useful outcome variable for ecological studies

     Article • International Journal of Infectious Diseases, May 2013, Elsevier

     Prof Robert Colebunders

345. 
     Change in quality of life: a follow up study among patients with HIV infection with and without TB in Ethiopia

     Article • BMC Public Health, April 2013, Springer Science + Business Media

     Prof Robert Colebunders

346. 
     Antiretroviral Drug Resistance Profiles and Response to Second-Line Therapy Among HIV Type 1-Infected Ugandan Children

     Article • AIDS Research and Human Retroviruses, March 2013, Mary Ann Liebert Inc

     Prof Robert Colebunders

347. 
     Birds of a feather: homophily and sexual network structure in sub-Saharan Africa

     Article • International Journal of STD & AIDS, March 2013, SAGE Publications

     Prof Robert Colebunders

348. 
     Hyperlactatemia and concurrent use of antiretroviral therapy among HIV infected patients in Uganda

     Article • African Health Sciences, January 2013, African Journals Online (AJOL)

     Prof Robert Colebunders

349. 
     Ellipse et fragment

     Article • January 2013, Peter Lang, International Academic Publishers

     Prof Robert Colebunders

350. 
     Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever Caused by a Newly Identified Virus Strain, Bundibugyo, Uganda, 2007–2008

     Article • PLoS ONE, December 2012, PLOS

     Prof Robert Colebunders

351. 
     Design of a cluster randomized trial assessing integrated infectious diseases training and on-site support for midlevel practitioners in Uganda

     Article • International Journal of Care Pathways, December 2012, SAGE Publications

     Prof Robert Colebunders

352. 
     Response to Antiretroviral Therapy of HIV Type 1-Infected Children in Urban and Rural Settings of Uganda

     Article • AIDS Research and Human Retroviruses, December 2012, Mary Ann Liebert Inc

     Prof Robert Colebunders

353. 
     Determinants of male involvement in maternal and child health services in sub-Saharan Africa: a review

     Article • Reproductive Health, November 2012, Springer Science + Business Media

     Prof Robert Colebunders

354. 
     Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia

     Article • British Journal of Clinical Pharmacology, November 2012, Wiley

     Prof Robert Colebunders

355. 
     Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years?

     Article • Expert Review of Anti-infective Therapy, November 2012, Taylor & Francis

     Lut Lynen, Prof Robert Colebunders

356. 
     Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis

     Article • The International Journal of Tuberculosis and Lung Disease, November 2012, International Union Against Tuberculosis and Lung Disease

     Prof Robert Colebunders

357. 
     Strong association between point-concurrency and national peak HIV prevalence

     Article • International Journal of Infectious Diseases, November 2012, Elsevier

     Prof Robert Colebunders

358. 
     Utilization of HIV and Tuberculosis Services by Health Care Workers in Uganda: Implications for Occupational Health Policies and Implementation

     Article • PLoS ONE, October 2012, PLOS

     Prof Robert Colebunders

359. 
     The efficacy of a brief intervention to reduce alcohol misuse in patients with HIV in South Africa: study protocol for a randomized controlled trial

     Article • Current Controlled Trials in Cardiovascular Medicine, October 2012, Springer Science + Business Media

     Diana Huis in 't Veld, Prof Robert Colebunders

360. 
     Depression and Posttraumatic Stress Disorder Among HIV-Infected Gambians on Antiretroviral Therapy

     Article • AIDS Patient Care and STDs, October 2012, Mary Ann Liebert Inc

     Prof Robert Colebunders

361. 
     Corticosteroid-modulated Immune Activation in the Tuberculosis Immune Reconstitution Inflammatory Syndrome

     Article • American Journal of Respiratory and Critical Care Medicine, August 2012, American Thoracic Society

     Prof Robert Colebunders

362. 
     What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?

     Article • PLoS Medicine, August 2012, PLOS

     Prof Robert Colebunders

363. 
     The Role of Raltegravir in the Treatment of HIV-2 Infections: Evidence from a Case Series

     Article • Antiviral Therapy, August 2012, SAGE Publications

     Prof Robert Colebunders

364. 
     Retention in a NGO Supported Antiretroviral Program in the Democratic Republic of Congo

     Article • PLoS ONE, July 2012, PLOS

     Prof Robert Colebunders

365. 
     Tuberculosis lymphadenitis in Southwest Ethiopia: a community based cross-sectional study

     Article • BMC Public Health, July 2012, Springer Science + Business Media

     Prof Robert Colebunders, Prof Gemeda Abebe

366. 
     Sub-Optimal Vitamin B-12 Levels among ART-Naïve HIV-Positive Individuals in an Urban Cohort in Uganda

     Article • PLoS ONE, July 2012, PLOS

     Prof Robert Colebunders

367. 
     Clinical Spectrum, Risk Factors and Outcome of Immune Reconstitution Inflammatory Syndrome in Patients with Tuberculosis–HIV Coinfection

     Article • Antiviral Therapy, July 2012, SAGE Publications

     Prof Robert Colebunders

368. 
     Corticosteroid Therapy, Vitamin D Status, and Inflammatory Cytokine Profile in the HIV-Tuberculosis Immune Reconstitution Inflammatory Syndrome

     Article • Clinical Infectious Diseases, June 2012, Oxford University Press (OUP)

     Anna Coussens, Prof Robert Colebunders

369. 
     Return to Normal Life After AIDS as a Reason for Lost to Follow-up in a Community-Based Antiretroviral Treatment Program

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2012, Wolters Kluwer Health

     Prof Robert Colebunders

370. 
     Predictors of condom use and refusal among the population of Free State province in South Africa

     Article • BMC Public Health, May 2012, Springer Science + Business Media

     Prof Robert Colebunders

371. 
     Strategies for Optimizing Clinic Efficiency in a Community-Based Antiretroviral Treatment Programme in Uganda

     Article • AIDS and Behavior, May 2012, Springer Science + Business Media

     Prof Robert Colebunders

372. 
     PhDs: Adapt training for developing world

     Article • Nature, May 2012, Springer Science + Business Media

     Prof Robert Colebunders

373. 
     Socioeconomic Support Reduces Nonretention in a Comprehensive, Community-Based Antiretroviral Therapy Program in Uganda

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2012, Wolters Kluwer Health

     Prof Robert Colebunders

374. 
     An Autopsy Study Describing Causes of Death and Comparing Clinico-Pathological Findings among Hospitalized Patients in Kampala, Uganda

     Article • PLoS ONE, March 2012, PLOS

     Prof Robert Colebunders

375. 
     Prevalence of pulmonary TB and spoligotype pattern of Mycobacterium tuberculosis among TB suspects in a rural community in Southwest Ethiopia

     Article • BMC Infectious Diseases, March 2012, Springer Science + Business Media

     Prof Robert Colebunders, Prof Gemeda Abebe

376. 
     A Randomized Controlled Trial to Evaluate the Effectiveness of a Board Game on Patients' Knowledge Uptake of HIV and Sexually Transmitted Diseases at the Infectious Diseases Institute, Kampala, Uganda

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2012, Wolters Kluwer Health

     Prof Robert Colebunders

377. 
     A Tale Of Two Epidemics Within TWO Countries

     Article • Journal of Adolescent Health, February 2012, Elsevier

     Prof Robert Colebunders

378. 
     Predictors of antiretroviral treatment-associated tuberculosis in Ethiopia: a nested case-control study

     Article • International Journal of STD & AIDS, February 2012, SAGE Publications

     Prof Robert Colebunders

379. 
     Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy

     Article • Expert Review of Anti-infective Therapy, January 2012, Taylor & Francis

     Diana Huis in 't Veld, Prof Robert Colebunders

380. 
     Immune Reconstitution Inflammatory Syndrome in HIV/AIDS

     Article • January 2012, Elsevier

     Prof Robert Colebunders

381. 
     Urinary Lipoarabinomannan as Predictor for the Tuberculosis Immune Reconstitution Inflammatory Syndrome

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2011, Wolters Kluwer Health

     Prof Robert Colebunders

382. 
     Filovirus Hemorrhagic Fever Outbreak Case Management: A Review of Current and Future Treatment Options

     Article • The Journal of Infectious Diseases, November 2011, Oxford University Press (OUP)

     Prof Robert Colebunders

383. 
     The immune reconstitution inflammatory syndrome related to HIV co-infections: a review

     Article • European Journal of Clinical Microbiology & Infectious Diseases, October 2011, Springer Science + Business Media

     Diana Huis in 't Veld, Prof Robert Colebunders

384. 
     Antiretroviral treatment in the private sector in Namibia

     Article • International Journal of STD & AIDS, October 2011, SAGE Publications

     Prof Robert Colebunders

385. 
     Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2011, Wolters Kluwer Health

     Dr Frank van Leth, Prof Robert Colebunders

386. 
     Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy

     Article • The International Journal of Tuberculosis and Lung Disease, August 2011, International Union Against Tuberculosis and Lung Disease

     Prof Robert Colebunders

387. 
     Association of haptoglobin phenotypes with the development of Kaposi’s sarcoma in HIV patients

     Article • Archives of Dermatological Research, July 2011, Springer Science + Business Media

     Prof Robert Colebunders

388. 
     Electronic Medical Records and Same Day Patient Tracing Improves Clinic Efficiency and Adherence to Appointments in a Community Based HIV/AIDS Care Program, in Uganda

     Article • AIDS and Behavior, July 2011, Springer Science + Business Media

     Prof Robert Colebunders

389. 
     Reducing mortality from HIV infection and tuberculosis

     Article • The Lancet Infectious Diseases, July 2011, Elsevier

     Prof Robert Colebunders

390. 
     Tuberculosis knowledge, attitudes and health-seeking behaviour in rural Uganda

     Article • The International Journal of Tuberculosis and Lung Disease, July 2011, International Union Against Tuberculosis and Lung Disease

     Prof Robert Colebunders

391. 
     Sexual Satisfaction Among Men Living with HIV in Europe

     Article • AIDS and Behavior, June 2011, Springer Science + Business Media

     Prof Robert Colebunders

392. 
     Autopsy acceptance rate and reasons for decline in Mulago Hospital, Kampala, Uganda

     Article • Tropical Medicine & International Health, May 2011, Wiley

     Prof Robert Colebunders

393. 
     Proposal to Adjust the WHO Clinical Staging System

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2011, Wolters Kluwer Health

     Prof Robert Colebunders

394. 
     Cured of fear of flying

     Article • Travel Medicine and Infectious Disease, March 2011, Elsevier

     Prof Robert Colebunders

395. 
     Male partner voluntary counselling and testing associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a randomized controlled trial

     Article • International Journal of STD & AIDS, March 2011, SAGE Publications

     Prof Robert Colebunders

396. 
     High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort

     Article • BMC Infectious Diseases, February 2011, Springer Science + Business Media

     Prof Robert Colebunders

397. 
     Tuberculosis drug resistance testing by molecular methods: Opportunities and challenges in resource limited settings

     Article • Journal of Microbiological Methods, February 2011, Elsevier

     Prof Gemeda Abebe, Prof Robert Colebunders

398. 
     Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART

     Article • Clinical and Developmental Immunology, January 2011, Hindawi Publishing Corporation

     Prof Robert Colebunders

399. 
     AWARENESS OF HEPATITIS C INFECTION AMONG MEN WHO HAVE SEX WITH MEN IN FLANDERS, BELGIUM

     Article • Acta Clinica Belgica, January 2011, Maney Publishing

     Prof Robert Colebunders

400. 
     Thoraco-abdominal Wall Reconstruction after Surgical Debulking of a Giant Retroperitoneal Liposarcoma: a Case Report

     Article • Acta Chirurgica Belgica, January 2011, Taylor & Francis

     Prof Robert Colebunders

401. 
     Body Weight Changes and Clinical Outcome in Adults on Antiretroviral Therapy in Countries With Limited Resources

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2010, Wolters Kluwer Health

     Diana Huis in 't Veld, Prof Robert Colebunders

402. 
     The immune reconstitution inflammatory syndrome and antiretroviral therapy

     Article • British Journal of Hospital Medicine, December 2010, Mark Allen Group

     Prof Robert Colebunders

403. 
     Nutritional Supplementation in HIV‐Infected Individuals Can Be Beneficial in Certain Patient Groups

     Article • Clinical Infectious Diseases, November 2010, Oxford University Press (OUP)

     Diana Huis in 't Veld, Prof Robert Colebunders

404. 
     Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin

     Article • Journal of Antimicrobial Chemotherapy, November 2010, Oxford University Press (OUP)

     Prof Robert Colebunders

405. 
     Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions

     Article • The Lancet Infectious Diseases, November 2010, Elsevier

     Prof Robert Colebunders

406. 
     Incidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy

     Article • International Journal of STD & AIDS, November 2010, SAGE Publications

     Prof Robert Colebunders

407. 
     Challenges in the diagnosis of meningitis in low-resource settings

     Article • Tropical Medicine & International Health, October 2010, Wiley

     Lut Lynen, Prof Robert Colebunders

408. 
     Knowledge, Health Seeking Behavior and Perceived Stigma towards Tuberculosis among Tuberculosis Suspects in a Rural Community in Southwest Ethiopia

     Article • PLoS ONE, October 2010, PLOS

     Prof Gemeda Abebe, Prof Robert Colebunders

409. 
     Sexual Protection Behavior in HIV-Positive Gay Men: Testing a Modified Information-Motivation-Behavioral Skills Model

     Article • Archives of Sexual Behavior, September 2010, Springer Science + Business Media

     Prof Robert Colebunders

410. 
     ART in low-resource settings: how to do more with less

     Article • The Lancet, August 2010, Elsevier

     Prof Robert Colebunders

411. 
     Alcohol and Antiretroviral Adherence? What About Africa?

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2010, Wolters Kluwer Health

     Prof Robert Colebunders

412. 
     Common mental disorders in TB/HIV co-infected patients in Ethiopia

     Article • BMC Infectious Diseases, July 2010, Springer Science + Business Media

     Prof Gemeda Abebe, Prof Robert Colebunders

413. 
     Prejudice and misconceptions about tuberculosis and HIV in rural and urban communities in Ethiopia: a challenge for the TB/HIV control program

     Article • BMC Public Health, July 2010, Springer Science + Business Media

     Prof Gemeda Abebe, Prof Robert Colebunders

414. 
     Mirror, mirror on the wall: the face of HIV + women in Europe today

     Article • AIDS Care, June 2010, Taylor & Francis

     Prof Robert Colebunders

415. 
     Buruli Ulcer Lesions in HIV-Positive Patient

     Article • Emerging Infectious Diseases, April 2010, Centers for Disease Control and Prevention (CDC)

     Prof Robert Colebunders

416. 
     Predictors of HIV Testing among Patients with Tuberculosis in North West Ethiopia: A Case-Control Study

     Article • PLoS ONE, March 2010, PLOS

     Prof Robert Colebunders

417. 
     The International Index of Erectile Function: Development of an Adapted Tool for Use in HIV-Positive Men Who Have Sex with Men

     Article • The Journal of Sexual Medicine, February 2010, Oxford University Press (OUP)

     Prof Robert Colebunders

418. 
     Role of the CD4 count in HIV management

     Article • HIV Therapy, January 2010, Future Medicine

     Prof Robert Colebunders

419. 
     The Prevalence and Causes of Visual Loss Among HIV-Infected Individuals in Uganda

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2010, Wolters Kluwer Health

     Prof Robert Colebunders

420. 
     Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria

     Article • Therapeutics and Clinical Risk Management, December 2009, Taylor & Francis

     Prof Robert Colebunders

421. 
     “It's Better Not To Know”: Perceived Barriers to HIV Voluntary Counseling and Testing among Sub-Saharan African Migrants in Belgium

     Article • AIDS Education and Prevention, December 2009, Guilford Publications

     Prof Robert Colebunders

422. 
     Tuberculosis and HIV co-infection: its impact on quality of life

     Article • Health and Quality of Life Outcomes, December 2009, Springer Science + Business Media

     Prof Robert Colebunders

423. 
     Provider-initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable

     Article • Tropical Medicine & International Health, October 2009, Wiley

     Prof Robert Colebunders

424. 
     An Algorithm to Optimize Viral Load Testing in HIV-Positive Patients With Suspected First-Line Antiretroviral Therapy Failure in Cambodia

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2009, Wolters Kluwer Health

     Prof Robert Colebunders

425. 
     Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia

     Article • Tropical Medicine & International Health, July 2009, Wiley

     Lut Lynen, Prof Robert Colebunders

426. 
     Pediatric HIV: new opportunities to treat children

     Article • Expert Opinion on Pharmacotherapy, June 2009, Taylor & Francis

     Prof Robert Colebunders

427. 
     Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?

     Article • The Journal of Infection in Developing Countries, June 2009, Journal of Infection in Developing Countries

     Prof Robert Colebunders

428. 
     HIV-1-Infected Individuals Traveling to Malaria Endemic Areas

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2009, Wolters Kluwer Health

     Prof Robert Colebunders

429. 
     Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need?

     Article • International Journal of STD & AIDS, June 2009, SAGE Publications

     Prof Robert Colebunders

430. 
     Successful Treatment of Psoriasis-like Lesions in HIV Infected Patients in Uganda with Chloroquine

     Article • The Open Infectious Diseases Journal, May 2009, Bentham Science Publishers

     Prof Robert Colebunders

431. 
     Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead

     Article • AIDS, May 2009, Wolters Kluwer Health

     Lut Lynen, Prof Robert Colebunders

432. 
     Coping with TB immune reconstitution inflammatory syndrome

     Article • Expert Review of Respiratory Medicine, April 2009, Taylor & Francis

     Prof Robert Colebunders

433. 
     Response to “Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes”

     Article • The Journal of Infectious Diseases, February 2009, Oxford University Press (OUP)

     Prof Robert Colebunders

434. 
     Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria

     Article • Journal of the International AIDS Society, February 2009, Springer Science + Business Media

     Prof Robert Colebunders

435. 
     Impact of HIV-1 Infection on the Hematological Recovery After Clinical Malaria

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2009, Wolters Kluwer Health

     Prof Robert Colebunders

436. 
     Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda

     Article • International Journal of STD & AIDS, February 2009, SAGE Publications

     Prof Robert Colebunders

437. 
     Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic

     Article • Journal of the International AIDS Society, January 2009, Wiley

     Prof Robert Colebunders

438. 
     Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?

     Article • AIDS Research and Therapy, January 2009, Springer Science + Business Media

     Prof Robert Colebunders

439. 
     Mortality and Associated Factors After Initiation of Pediatric Antiretroviral Treatment in the Democratic Republic of the Congo

     Article • The Pediatric Infectious Disease Journal, January 2009, Wolters Kluwer Health

     Prof Robert Colebunders

440. 
     Three-Year Outcome Data of Second-Line Antiretroviral Therapy in Ugandan Adults: Good Virological Response but High Rate of Toxicity

     Article • Journal of the International Association of Physicians in AIDS Care, January 2009, SAGE Publications

     Prof Robert Colebunders

441. 
     Biology and Natural History of Acquired Immunodeficiency Syndrome

     Article • January 2009, Elsevier

     Prof Robert Colebunders

442. 
     Fatal and Fulminant Infections

     Article • January 2009, Elsevier

     Prof Robert Colebunders

443. 
     A Visual Dosing Aid for First-line Pediatric Antiretroviral Treatment in Resource-poor Settings

     Article • Journal of Tropical Pediatrics, October 2008, Oxford University Press (OUP)

     Prof Robert Colebunders

444. 
     Differences in perceptions on sexual and reproductive health between service providers and people living with HIV: A qualitative elicitation study

     Article • Psychology Health & Medicine, October 2008, Taylor & Francis

     Prof Robert Colebunders

445. 
     Episodic Antiretroviral Therapy Increases HIV Transmission Risk Compared With Continuous Therapy: Results of a Randomized Controlled Trial

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2008, Wolters Kluwer Health

     Prof Robert Colebunders

446. 
     Universal access to HIV care: pitfalls and the way forward

     Article • Tropical Medicine & International Health, October 2008, Wiley

     Prof Robert Colebunders

447. 
     Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other

     Article • Tropical Medicine & International Health, September 2008, Wiley

     Prof Robert Colebunders

448. 
     Fever After a Stay in the Tropics: Clinical Spectrum and Outcome in HIV-Infected Travelers and Migrants

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2008, Wolters Kluwer Health

     Prof Robert Colebunders

449. 
     Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

     Article • The Lancet Infectious Diseases, August 2008, Elsevier

     Lut Lynen, Prof Robert Colebunders

450. 
     The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance

     Article • Malaria Journal, July 2008, Springer Science + Business Media

     Prof Robert Colebunders

451. 
     HIV education for health-care professionals in high prevalence countries: time to integrate a pre-service approach into training

     Article • The Lancet, July 2008, Elsevier

     Prof Robert Colebunders

452. 
     Immune restoration disease

     Article • Current Opinion in HIV and AIDS, July 2008, Wolters Kluwer Health

     Prof Robert Colebunders

453. 
     Determination of the Incidence of Tuberculosis in Low‐Income Countries

     Article • Clinical Infectious Diseases, May 2008, Oxford University Press (OUP)

     Prof Robert Colebunders

454. 
     HIV care and treatment for children in resource-limited settings

     Article • Expert Review of Anti-infective Therapy, April 2008, Taylor & Francis

     Prof Robert Colebunders

455. 
     Pediatric HIV infection: the state of antiretroviral therapy

     Article • Expert Review of Anti-infective Therapy, April 2008, Taylor & Francis

     Prof Robert Colebunders

456. 
     Sexual risk reduction needs of adolescents living with HIV in a clinical care setting

     Article • AIDS Care, April 2008, Taylor & Francis

     Prof Robert Colebunders

457. 
     Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility

     Article • BMC Infectious Diseases, March 2008, Springer Science + Business Media

     Prof Robert Colebunders

458. 
     Increased Risk for Entamoeba histolytica Infection and Invasive Amebiasis in HIV Seropositive Men Who Have Sex with Men in Taiwan

     Article • PLoS Neglected Tropical Diseases, February 2008, PLOS

     Prof Robert Colebunders

459. 
     Evaluation of the GIDEON Expert Computer Program for the Diagnosis of Imported Febrile Illnesses

     Article • Medical Decision Making, February 2008, SAGE Publications

     Prof Robert Colebunders

460. 
     Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?

     Article • AIDS, January 2008, Wolters Kluwer Health

     Prof Robert Colebunders

461. 
     Marburg Hemorrhagic Fever in Durba and Watsa, Democratic Republic of the Congo: Clinical Documentation, Features of Illness, and Treatment

     Article • The Journal of Infectious Diseases, November 2007, Oxford University Press (OUP)

     Prof Robert Colebunders

462. 
     Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough?

     Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, November 2007, Oxford University Press (OUP)

     Lut Lynen, Prof Robert Colebunders

463. 
     Current Hemoglobin Levels Are More Predictive of Disease Progression Than Hemoglobin Measured at Baseline in Patients Receiving Antiretroviral Treatment for HIV Type 1 Infection

     Article • AIDS Research and Human Retroviruses, October 2007, Mary Ann Liebert Inc

     Prof Robert Colebunders

464. 
     Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2007, Wolters Kluwer Health

     Prof Robert Colebunders

465. 
     Pulmonary cystic disease in HIV positive individuals in the Democratic Republic of Congo: three case reports

     Article • Journal of Medical Case Reports, September 2007, Springer Science + Business Media

     Prof Robert Colebunders

466. 
     Sexual dysfunction in HIV-positive men is multi-factorial: A study of prevalence and associated factors

     Article • AIDS Care, September 2007, Taylor & Francis

     Prof Robert Colebunders

467. 
     Vena cava inferior thrombosis detected by venous hum: a case report

     Article • Journal of Medical Case Reports, August 2007, Springer Science + Business Media

     Prof Robert Colebunders

468. 
     Lessons Learned From 2 Patients With Multidrug-Resistant HIV-1 Infection Successfully Treated With a Darunavir-Containing Antiretroviral Treatment Regimen

     Article • Journal of the International Association of Physicians in AIDS Care, June 2007, SAGE Publications

     Prof Robert Colebunders

469. 
     When to switch for antiretroviral treatment failure in resource-limited settings?

     Article • AIDS, May 2007, Wolters Kluwer Health

     Prof Robert Colebunders

470. 
     IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN AN HIV/TB CO-INFECTED PATIENT FOUR YEARS AFTER STARTING ANTIRETROVIRAL THERAPY

     Article • Acta Clinica Belgica, April 2007, Taylor & Francis

     Prof Robert Colebunders

471. 
     Quality of Life in HIV Clinical Trials: Why Sexual Health Must Not Be Ignored

     Article • PLoS Clinical Trials, March 2007, PLOS

     Prof Robert Colebunders

472. 
     Selective ambulatory management of imported falciparum malaria: a 5-year prospective study

     Article • European Journal of Clinical Microbiology & Infectious Diseases, February 2007, Springer Science + Business Media

     Prof Robert Colebunders

473. 
     Tuberculosis in resource poor countries

     Article • BMJ, January 2007, BMJ

     Prof Robert Colebunders

474. 
     Assessment of the patient flow at the infectious diseases institute out-patient clinic, Kampala, Uganda

     Article • AIDS Care, January 2007, Taylor & Francis

     Prof Robert Colebunders

475. 
     Fever After a Stay in the Tropics

     Article • Medicine, January 2007, Wolters Kluwer Health

     Prof Robert Colebunders

476. 
     HIV‐1 Immune Suppression and Antimalarial Treatment Outcome in Zambian Adults with Uncomplicated Malaria

     Article • The Journal of Infectious Diseases, October 2006, Oxford University Press (OUP)

     Prof Robert Colebunders

477. 
     Remote consultations and HIV/AIDS continuing education in low-resource settings

     Article • International Journal of Medical Informatics, September 2006, Elsevier

     Lut Lynen, Prof Robert Colebunders

478. 
     Réponse des auteurs

     Article • Annales de Pathologie, September 2006, Elsevier

     Prof Robert Colebunders

479. 
     Marburg Hemorrhagic Fever Associated with Multiple Genetic Lineages of Virus

     Article • New England Journal of Medicine, August 2006, New England Journal of Medicine (NEJM/MMS)

     Prof Robert Colebunders

480. 
     Etiology and Outcome of Fever After a Stay in the Tropics

     Article • Archives of Internal Medicine, August 2006, American Medical Association (AMA)

     Prof Robert Colebunders

481. 
     Authors' reply

     Article • The Lancet Infectious Diseases, July 2006, Elsevier

     Lut Lynen, Prof Robert Colebunders

482. 
     The Added Value of a CD4 Count to Identify Patients Eligible for Highly Active Antiretroviral Therapy Among HIV-Positive Adults in Cambodia

     Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2006, Wolters Kluwer Health

     Lut Lynen, Prof Robert Colebunders

483. 
     HIV Eosinophilic Folliculitis in Uganda

     Article • Archives of Dermatology, July 2006, American Medical Association (AMA)

     Prof Robert Colebunders

484. 
     IMPORTED NON–PLASMODIUM FALCIPARUM MALARIA: A FIVE-YEAR PROSPECTIVE STUDY IN A EUROPEAN REFERRAL CENTER

     Article • American Journal of Tropical Medicine and Hygiene, July 2006, American Society of Tropical Medicine and Hygiene

     Prof Robert Colebunders

485. 
     Infectious Mononucleosis–Like Syndromes in Febrile Travelers Returning From the Tropics

     Article • Journal of Travel Medicine, July 2006, Oxford University Press (OUP)

     Prof Robert Colebunders

486. 
     Unexpected improvement of sexual dysfunction during atazanavir therapy

     Article • AIDS, May 2006, Wolters Kluwer Health

     Prof Robert Colebunders

487. 
     Imported Katayama fever: Clinical and biological features at presentation and during treatment

     Article • Journal of Infection, May 2006, Elsevier

     Prof Robert Colebunders

488. 
     Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins

     Article • Blood, March 2006, American Society of Hematology

     Prof Robert Colebunders

489. 
     PORTAL VEIN THROMBOSIS IN A PATIENT WITH HIV TREATED WITH A PROTEASE INHIBITOR-CONTAINING REGIMEN

     Article • Acta Clinica Belgica, February 2006, Taylor & Francis

     Prof Robert Colebunders

490. 
     Reply to Lawn and Wood

     Article • Clinical Infectious Diseases, February 2006, Oxford University Press (OUP)

     Prof Robert Colebunders

491. 
     A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries

     Article • The Lancet Infectious Diseases, January 2006, Elsevier

     Lut Lynen, Prof Robert Colebunders

492. 
     Mycobacterium-associated immune reconstitution disease: macrophages running wild?

     Article • The Lancet Infectious Diseases, January 2006, Elsevier

     Prof Robert Colebunders

493. 
     Review editorial: Prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment

     Article • Tropical Medicine & International Health, December 2005, Wiley

     Lut Lynen, Prof Robert Colebunders

494. 
     Response to ‘Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?’ AIDS, 22 July 2005

     Article • AIDS, November 2005, Wolters Kluwer Health

     Prof Robert Colebunders

495. 
     Pulmonary Sporothrix schenckii Infection in a HIV Positive Child

     Article • Journal of Tropical Pediatrics, November 2005, Oxford University Press (OUP)

     Prof Robert Colebunders

496. 
     The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk

     Article • AIDS, November 2005, Wolters Kluwer Health

     Prof Robert Colebunders

497. 
     Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time

     Article • AIDS, October 2005, Wolters Kluwer Health

     Prof Robert Colebunders

498. 
     Corrélations anatomo-biologiques dans un cas de fièvre jaune importé de Gambie

     Article • Annales de Pathologie, October 2005, Elsevier

     Prof Robert Colebunders

499. 
     Free Antiretrovirals Must Not Be Restricted Only to Treatment-Naive Patients

     Article • PLoS Medicine, September 2005, PLOS

     Prof Robert Colebunders

500. 
     Palliative care in sub-Saharan Africa

     Article • The Lancet, August 2005, Elsevier

     Lut Lynen, Prof Robert Colebunders

501. 
     Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium

     Article • Journal of Clinical Virology, August 2005, Elsevier

     Prof Robert Colebunders

502. 
     Rolling Out Antiretrovirals in Africa: There Are Still Challenges Ahead

     Article • Clinical Infectious Diseases, August 2005, Oxford University Press (OUP)

     Prof Robert Colebunders

503. 
     Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression

     Article • Journal of Virology, July 2005, ASM Journals

     Prof Robert Colebunders

504. 
     BILATERAL BLINDNESS AFTER STARTING HIGHLY ACTIVE ANTIRETROVIRAL TREATMENT IN A PATIENT WITH HIV INFECTION AND CRYPTOCOCCAL MENINGITIS

     Article • Acta Clinica Belgica, February 2005, Taylor & Francis

     Prof Robert Colebunders

505. 
     Risk factors for and types of oesophageal cancer

     Article • The Lancet, December 2004, Elsevier

     Prof Robert Colebunders

506. 
     Merkel cell carcinoma and multiple basal cell carcinoma in an African albino woman with HIV infection

     Article • HIV Medicine, November 2004, Wiley

     Prof Robert Colebunders

507. 
     Efavirenz-Associated Stevens-Johnson Syndrome

     Article • Infection, October 2004, Springer Science + Business Media

     Prof Robert Colebunders

508. 
     Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection

     Article • International Journal of Infectious Diseases, September 2004, Elsevier

     Prof Robert Colebunders

509. 
     Five-year immunological outcome of highly active antiretroviral treatment in a clinical setting: results from a single HIV treatment centre

     Article • International Journal of STD & AIDS, August 2004, SAGE Publications

     Prof Robert Colebunders

510. 
     The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment

     Article • International Journal of STD & AIDS, August 2004, SAGE Publications

     Prof Robert Colebunders

511. 
     Families affected by HIV: Parents’ and children's characteristics and disclosure to the children

     Article • AIDS Care, July 2004, Taylor & Francis

     Prof Robert Colebunders

512. 
     Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe

     Article • AIDS Care, July 2004, Taylor & Francis

     Prof Robert Colebunders

513. 
     Organisation of health care during an outbreak of Marburg haemorrhagic fever in the Democratic Republic of Congo, 1999

     Article • Journal of Infection, May 2004, Elsevier

     Prof Robert Colebunders

514. 
     Development, Evaluation, and Validation of an Oligonucleotide Probe Hybridization Assay To Subtype Human Immunodeficiency Virus Type 1 Circulating Recombinant Form CRF02_AG

     Article • Journal of Clinical Microbiology, April 2004, ASM Journals

     Prof Robert Colebunders

515. 
     Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

     Article • AIDS, January 2004, Wolters Kluwer Health

     Prof Robert Colebunders

516. 
     Mixed Arterial and Venous Thromboembolism in a Person with HIV Infection

     Article • Scandinavian Journal of Infectious Diseases, December 2003, Taylor & Francis

     Prof Robert Colebunders

517. 
     Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo

     Article • Emerging Infectious Diseases, December 2003, Centers for Disease Control and Prevention (CDC)

     Prof Robert Colebunders

518. 
     Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir

     Article • Journal of Infection, October 2003, Elsevier

     Prof Robert Colebunders

519. 
     The use of complementary and alternative medicine by persons with HIV infection in Europe

     Article • International Journal of STD & AIDS, October 2003, SAGE Publications

     Prof Robert Colebunders

520. 
     Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases

     Article • Journal of Medical Virology, September 2003, Wiley

     Prof Robert Colebunders

521. 
     Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment

     Article • Journal of Infection, August 2003, Elsevier

     Prof Robert Colebunders

522. 
     Current thinking on the management of tuberculosis

     Article • Current Opinion in Pulmonary Medicine, May 2003, Wolters Kluwer Health

     Prof Robert Colebunders

523. 
     Editorial: Giving antiretrovirals in the peripartum period to prevent mother-to-child HIV transmission in low-income countries: only a short-term stopgap measure

     Article • Tropical Medicine & International Health, May 2003, Wiley

     Prof Robert Colebunders

524. 
     Multiple Tuberculous Brain Abscesses in an HIV-Infected Patient Successfully Treated with HAART and Antituberculous Treatment

     Article • Infection, March 2003, Springer Science + Business Media

     Prof Robert Colebunders

525. 
     Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of ?-chemokines in contrast to infected humans

     Article • Journal of Medical Virology, January 2003, Wiley

     Professor Jonathan Luke Heeney, Prof Robert Colebunders

526. 
     Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?

     Article • International Journal of STD & AIDS, January 2003, SAGE Publications

     Lut Lynen, Prof Robert Colebunders

527. 
     HIV and sexual dysfunction

     Article • International Journal of STD & AIDS, January 2003, SAGE Publications

     Prof Robert Colebunders

528. 
     FEVER AFTER A STAY IN THE TROPICS

     Article • Acta Clinica Belgica, December 2002, Taylor & Francis

     Prof Robert Colebunders

529. 
     FEVER AFTER A STAY IN THE TROPICS

     Article • Acta Clinica Belgica, December 2002, Taylor & Francis

     Prof Robert Colebunders

530. 
     Regional and temporal changes in AIDS in Europe before HAART

     Article • Epidemiology and Infection, December 2002, Cambridge University Press

     Prof Robert Colebunders

531. 
     A Belgian Traveler Who Acquired Yellow Fever in The Gambia

     Article • Clinical Infectious Diseases, November 2002, Oxford University Press (OUP)

     Prof Robert Colebunders

532. 
     Short communication: A cluster of Marburg virus disease involving an infant*

     Article • Tropical Medicine & International Health, October 2002, Wiley

     Prof Robert Colebunders

533. 
     Financial situation of people living with HIV in Europe

     Article • International Journal of STD & AIDS, October 2002, SAGE Publications

     Prof Robert Colebunders

534. 
     IMPORTED VIRAL HAEMORRHAGIC FEVER WITH A POTENTIAL FOR PERSON-TO-PERSON TRANSMISSION : REVIEW AND RECOMMENDATIONS FOR INITIAL MANAGEMENT OF A SUSPECTED CASE IN BELGIUM

     Article • Acta Clinica Belgica, October 2002, Taylor & Francis

     Prof Robert Colebunders

535. 
     DEVELOPMENT OF MULTIPLE ABSCESSES IN AN HIV/TB CO-INFECTED PATIENT AFTER INITIATION OF ANTITUBERCULOUS AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

     Article • Acta Clinica Belgica, August 2002, Taylor & Francis

     Prof Robert Colebunders

536. 
     PATIENTS WITH HIV INFECTION AND FEVER: A DIAGNOSTIC APPROACH

     Article • Acta Clinica Belgica, August 2002, Taylor & Francis

     Prof Robert Colebunders

537. 
     Self-reported signs of lipodystrophy by persons living with HIV infection

     Article • International Journal of STD & AIDS, June 2002, SAGE Publications

     Prof Robert Colebunders

538. 
     Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression

     Article • Vaccine, May 2002, Elsevier

     Prof Robert Colebunders

539. 
     Management of co-infection with HIV and TB

     Article • BMJ, April 2002, BMJ

     Prof Robert Colebunders

540. 
     Do Patents Prevent Access to Drugs for HIV in Developing Countries?

     Article • JAMA, February 2002, American Medical Association (AMA)

     Lut Lynen, Prof Robert Colebunders

541. 
     Neuropsychiatric reaction induced by clarithromycin

     Article • Sexually Transmitted Infections, February 2002, BMJ

     Prof Robert Colebunders

542. 
     A Multidrug, Including Voriconazole, Resistant Oral Candida Infection in an AIDS Patient Effectively Treated with Echinocandin

     Article • Journal of Infection, January 2002, Elsevier

     Prof Robert Colebunders

543. 
     Rheumatological complications associated with the use of indinavir and other protease inhibitors

     Article • Annals of the Rheumatic Diseases, January 2002, BMJ

     Prof Robert Colebunders

544. 
     Direct costs of health care for HIV/AIDS patients in Belgium

     Article • AIDS Care, December 2001, Taylor & Francis

     Prof Robert Colebunders

545. 
     Imported case of confirmed yellow fever detected in Belgium

     Article • Weekly releases (1997–2007), November 2001, European Centre for Disease Control and Prevention (ECDC)

     Prof Robert Colebunders

546. 
     Diagnosis at first glance: nodular hepatic lesions in persons with AIDS

     Article • Clinical Microbiology and Infection, October 2001, Elsevier

     Prof Robert Colebunders

547. 
     Hospital based clinical surveillance for dengue haemorrhagic fever in Bandung, Indonesia 1994–1995

     Article • Acta Tropica, October 2001, Elsevier

     Prof Robert Colebunders

548. 
     Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment

     Article • AIDS, May 2001, Wolters Kluwer Health

     Prof Robert Colebunders

549. 
     Hospital services for people with HIV infection in Flanders: Patients' satisfaction

     Article • AIDS Care, April 2001, Taylor & Francis

     Prof Robert Colebunders

550. 
     Predominance of HIV Type 1 Subtype G among Commercial Sex Workers from Kinshasa, Democratic Republic of Congo

     Article • AIDS Research and Human Retroviruses, March 2001, Mary Ann Liebert Inc

     Prof Robert Colebunders

551. 
     Book: HIV

     Article • BMJ, February 2001, BMJ

     Prof Robert Colebunders

552. 
     Antiretroviral treatments used among adults with HIV infection in Europe

     Article • AIDS Care, February 2001, Taylor & Francis

     Prof Robert Colebunders

553. 
     Participants in HIV clinical trials in Europe

     Article • International Journal of STD & AIDS, February 2001, SAGE Publications

     Prof Robert Colebunders

554. 
     Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: A partial solution to Africa's HIV/AIDS problem?

     Article • International Journal of Infectious Diseases, January 2001, Elsevier

     Prof Robert Colebunders

555. 
     T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB)

     Article • Clinical & Experimental Immunology, December 2000, Oxford University Press (OUP)

     Prof Robert Colebunders

556. 
     Utilization of healthcare services by people living with HIV/AIDS in Europe

     Article • International Journal of STD & AIDS, December 2000, SAGE Publications

     Prof Robert Colebunders

557. 
     A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression

     Article • Journal of Virology, October 2000, ASM Journals

     Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu, Prof Robert Colebunders

558. 
     AIDS caused by HIV1 and HIV2 infection: are there clinical differences? Results of AIDS surveillance 1986-97 at Fann Hospital in Dakar, Senegal

     Article • Tropical Medicine & International Health, October 2000, Wiley

     Prof Robert Colebunders

559. 
     Natural Residues versus Antiretroviral Drug-Selected Mutations in HIV Type 1 Group O Reverse Transcriptase and Protease Related to Virological Drug Failurein Vivo

     Article • AIDS Research and Human Retroviruses, September 2000, Mary Ann Liebert Inc

     Prof Robert Colebunders

560. 
     Near Full-Length Genome Analysis of HIV Type 1 CRF02.AG, Subtype C and CRF02.AG Subtype G Recombinants

     Article • AIDS Research and Human Retroviruses, August 2000, Mary Ann Liebert Inc

     Prof Robert Colebunders

561. 
     Curly Hair and Lipodystrophy as a Result of Highly Active Antiretroviral Treatment?

     Article • Archives of Dermatology, August 2000, American Medical Association (AMA)

     Prof Robert Colebunders

562. 
     LETTERS TO THE EDITOR

     Article • Journal of Infection, July 2000, Elsevier

     Prof Robert Colebunders

563. 
     Impact of New Developments in Antiretroviral Treatment on AIDS Prevention and Care in Resource-Poor Countries

     Article • AIDS Patient Care and STDs, May 2000, Mary Ann Liebert Inc

     Prof Robert Colebunders

564. 
     Viewpoint: Filovirus haemorrhagic fever outbreaks: much ado about nothing?

     Article • Tropical Medicine & International Health, May 2000, Wiley

     Prof Robert Colebunders

565. 
     Cutaneous Ulcer Caused by Mycobacterium avium and Recurrent Genital Herpes After Highly Active Antiretroviral Therapy

     Article • Archives of Dermatology, January 2000, American Medical Association (AMA)

     Prof Robert Colebunders

566. 
     Ebola Haemorrhagic Fever – a Review

     Article • Journal of Infection, January 2000, Elsevier

     Prof Robert Colebunders

567. 
     Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates

     Article • Journal of Medical Virology, January 2000, Wiley

     Prof Robert Colebunders

568. 
     Multicentric Castleman’s Disease in 2 Patients with HIV Infection, Unresponsive to Antiviral Therapy

     Article • Acta Clinica Belgica, January 2000, Taylor & Francis

     Prof Robert Colebunders

569. 
     Q Fever After A Journey In Syria: A Diagnosis Suggested by Bone Marrow Biopsy

     Article • Acta Clinica Belgica, January 2000, Taylor & Francis

     Prof Robert Colebunders

570. 
     Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy

     Article • AIDS, January 2000, Wolters Kluwer Health

     Prof Robert Colebunders

571. 
     Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection

     Article • Journal of the American Academy of Dermatology, November 1999, Elsevier

     Prof Robert Colebunders

572. 
     Euthanasia and End-of-Life Care

     Article • JAMA, April 1999, American Medical Association (AMA)

     Prof Robert Colebunders

573. 
     Treatment and Prevention of Multidrug-Resistant Tuberculosis

     Article • Drugs, January 1999, Springer Science + Business Media

     Prof Robert Colebunders

574. 
     Sequence Note: HIV Type 1 C2V3 env Diversity among Belgian Individuals

     Article • AIDS Research and Human Retroviruses, September 1998, Mary Ann Liebert Inc

     Prof Robert Colebunders

575. 
     Recurrence of blackwater fever: triggering of relapses by different antimalarials

     Article • Tropical Medicine & International Health, August 1998, Wiley

     Prof Robert Colebunders

576. 
     Painful hyperaesthesia caused by protease inhibitors?

     Article • Infection, July 1998, Springer Science + Business Media

     Prof Robert Colebunders

577. 
     Deafness Caused by Didanosine

     Article • European Journal of Clinical Microbiology & Infectious Diseases, June 1998, Springer Science + Business Media

     Prof Robert Colebunders

578. 
     Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: predisposing factors, epidemiology and antifungal susceptibility

     Article • Mycoses, May 1998, Wiley

     Prof Robert Colebunders

579. 
     Deafness caused by didanosine

     Article • European Journal of Clinical Microbiology & Infectious Diseases, March 1998, Springer Science + Business Media

     Prof Robert Colebunders

580. 
     Splenic Rupture as a Complication ofP. FalciparumMalaria After Residence in The Tropics. Report of Two Cases.

     Article • Acta Clinica Belgica, January 1998, Taylor & Francis

     Prof Robert Colebunders

581. 
     Eosinophilia in Patients Infected with Human Immunodeficiency Virus

     Article • The Journal of Infectious Diseases, May 1997, Oxford University Press (OUP)

     Prof Robert Colebunders

582. 
     Histoplasma Capsulatum Infection in Three AIDS Patients Living in Africa

     Article • Scandinavian Journal of Infectious Diseases, January 1995, Taylor & Francis

     Prof Robert Colebunders

583. 
     Bordetella pertussis as a cause of chronic respiratory infection in an AIDS patient

     Article • European Journal of Clinical Microbiology & Infectious Diseases, April 1994, Springer Science + Business Media

     Prof Robert Colebunders

584. 
     HIV diagnosis delay in Antwerp, Belgium.

     Article • Journal of Epidemiology & Community Health, April 1994, BMJ

     Prof Robert Colebunders

585. 
     The Interleukin-2 Receptor Subunit Expression and Function on Peripheral Blood Lymphocytes from HIV-Infected and Control Persons

     Article • Clinical Immunology and Immunopathology, April 1994, Elsevier

     Prof Robert Colebunders

586. 
     Surveillance case definition for AIDS in resource-poor countries

     Article • The Lancet, October 1993, Elsevier

     Prof Robert Colebunders

587. 
     Priorities for HIV testing in developing countries?

     Article • The Lancet, September 1993, Elsevier

     Prof Robert Colebunders

588. 
     Bibliographie

     Article • June 1993, CAIRN

     Prof Robert Colebunders

589. 
     Imported Relapsing Fever in European Tourists

     Article • Scandinavian Journal of Infectious Diseases, January 1993, Taylor & Francis

     Prof Robert Colebunders

590. 
     Orthostatic hypotension in HIV infection in Africa

     Article • Journal of Infection, January 1993, Elsevier

     Prof Robert Colebunders

591. 
     Pulmonary T-Cell Lymphoma in a Patient with the Acquired Immunodeficiency Syndrome

     Article • Clinical Infectious Diseases, January 1993, Oxford University Press (OUP)

     Prof Robert Colebunders

592. 
     The Prevalence of Hairy Leukoplakia in HIV Seropositive and HIV Seronegative Immunocompromised Patients

     Article • International Journal of STD & AIDS, July 1992, SAGE Publications

     Prof Robert Colebunders

593. 
     Psoriasis regression in terminal AIDS

     Article • The Lancet, May 1992, Elsevier

     Prof Robert Colebunders

594. 
     An African Patient With Aids And Linitis Plastica

     Article • Acta Clinica Belgica, January 1992, Taylor & Francis

     Prof Robert Colebunders

595. 
     For debate. AIDS surveillance in Africa: a reappraisal of case definitions.

     Article • BMJ, November 1991, BMJ

     Prof Robert Colebunders

596. 
     Increased Mortality and Tuberculosis Treatment Failure Rate among Human Immunodeficiency Virus (HIV) Seropositive Compared with HIV Seronegative Patients with Pulmonary Tuberculosis Treated with “Standard” Chemotherapy in Kinshasa, Zaire

     Article • American Review of Respiratory Disease, October 1991, American Thoracic Society

     Prof Robert Colebunders

597. 
     Seroconversion Rate, Mortality, and Clinical Manifestations Associated with the Receipt of a Human Immunodeficiency Virus-Infected Blood Transfusion in Kinshasa, Zaire

     Article • The Journal of Infectious Diseases, September 1991, Oxford University Press (OUP)

     Prof Robert Colebunders

598. 
     Treatment for Kaposi's sarcoma in HIV-negative, non-homosexual men

     Article • The Lancet, April 1991, Elsevier

     Prof Robert Colebunders

599. 
     Mefloquine-induced Stevens-Johnson syndrome

     Article • The Lancet, March 1991, Elsevier

     Prof Robert Colebunders

600. 
     The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire

     Article • JAMA, January 1988, American Medical Association (AMA)

     Prof Robert Colebunders

601. 
     BCG Vaccine Abscesses Are Unrelated to HIV Infection

     Article • JAMA, January 1988, American Medical Association (AMA)

     Prof Robert Colebunders

602. 
     Association Between HTLV-III/ LAV Infection and Tuberculosis in Zaire

     Article • JAMA, July 1986, American Medical Association (AMA)

     Prof Robert Colebunders

603. 
     Carcinoid Heart Disease

     Article • Archives of Internal Medicine, February 1984, American Medical Association (AMA)

     Prof Robert Colebunders

604. 
     Carcinoid heart disease

     Article • Archives of Internal Medicine, February 1984, American Medical Association (AMA)

     Prof Robert Colebunders

605. 
     Opportunistic Infections

     Article • Springer Science + Business Media

     Prof Robert Colebunders